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ABSTRACT

BARRIERS AND FACILITATORS TO DIABETES SELF-MANAGEMENT IN A PRIMARY
CARE SETTING – PATIENT AND PHYSICIAN PERSPECTIVES

By
Rahul Khairnar
May 2017

Thesis Supervised by Dr. Khalid M. Kamal
OBJECTIVES: To identify patient- and physician-perceived barriers to self-management of
type-2 diabetes (T2DM) and explore the challenges physicians face in managing these patients.
METHODS: This cross-sectional study of T2DM patients and their physicians used a mixedmethods approach (combination of patient survey and electronic medical record (EMR)
database). A random stratified sample of 2,100 patients (age≥18 years) with a recorded diagnosis
of T2DM (ICD-9 code: 250.xx) and having ≥2 physician visits was selected from a large
physician group’s EMR database, and based on HbA1c level, was categorized into three groups:
HbA1c<7, 7–9, and >9. Patients were administered a survey containing standardized instruments
to collect information on demographics and diabetes self-care behaviors. Physician survey
measured physician perceptions of patient barriers to self-management and their challenges in
managing uncontrolled T2DM patients. RESULTS: 210 responses were received (10%
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response rate). Mean age was 63.68 years (+/-11.79), 102 (48.6%) were females, 197 were
Caucasian (93.8%). Univariate analysis revealed that age (X2=15.73, p<0.01), insurance status
(X2=12.03, p<0.05), referral to an endocrinologist (X2=6.17, p<0.05), level of self-management
(X2=12.01, p<0.05), and willingness to take insulin (X2=9.8, p<0.01) were associated with
HbA1c control. Older age, lower willingness to take insulin, and less than graduate level
education were significant determinants of glycemic control. Of the 21 physicians who
responded (53.8% response rate), 71.2% were over the age of 50 years, 54.16% had ≥25 years of
clinical experience, and 50% practiced in an urban setting. Barriers leading to clinical inertia as
identified by the physicians include cost of medications, non-compliance with diet and
medications, polypharmacy, lack of patient motivation, knowledge, time, and social support.
CONCLUSIONS: Self-management behavior of T2DM patients is strongly associated with
HbA1c control. Interventions directed towards improving self-management in T2DM population
that take both physician and patient perspectives in to consideration may result in improved
clinical outcomes.
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CHAPTER ONE – INTRODUCTION
Diabetes Mellitus – An Overview
Diabetes Mellitus (DM), or simply Diabetes, is a group of metabolic disorders
characterized by inefficient utilization of blood glucose.1 Glucose is the primary source of energy
for the body. Insulin, a hormone secreted by pancreas, facilitates the uptake of blood glucose by
body cells and tissues. In a healthy individual, the pancreas secretes adequate amounts of insulin
required for this blood glucose transfer. This secretion is triggered by the amount of food
consumed by an individual. In an individual with DM, there is either little or no production of
insulin by the pancreas, or improper utilization of insulin by body cells, or a combination of
both.2
The three most commonly recognized forms of diabetes are as follows3:
1. Type 1 Diabetes Mellitus (T1DM) OR Insulin Dependent Diabetes Mellitus (IDDM)
2. Type 2 Diabetes Mellitus (T2DM) OR Non-Insulin Dependent Diabetes Mellitus
(NIDDM)
3. Gestational Diabetes
T1DM is an autoimmune disorder where the body produces antibodies against its own
pancreas. These antibodies damage the pancreas and stop insulin production. The etiology of
T1DM is unclear. It may be caused by genetic predisposition, environmental factors, or as a
result of faulty beta cells in the pancreas which normally produce insulin.1 T1DM accounts for
around 5 – 10% of the diagnosed cases of diabetes in the United States (US).3
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T2DM, also known as Non-Insulin Dependent Diabetes Mellitus (NIDDM), is the most
common form of diabetes accounting for around 90% of the 26 million Americans with diabetes.
It occurs due to insufficient or no production of insulin by the pancreas, or ineffective utilization
of insulin by body cells due to insulin resistance. It has been observed that African Americans,
Latinos, Native Americans, and Asian Americans (Pacific Islanders) are at an increased risk of
developing T2DM.2 Aging, obesity, family history of diabetes, previous history of gestational
diabetes, and physical inactivity are other factors associated with T2DM. Over 80% of the
patients with T2DM are overweight.4
Gestational diabetes is a form of glucose intolerance that occurs in 2 – 10% of pregnant
women due to pregnancy.5 It can cause several health problems during pregnancy, to both
mother and child. Women with gestational diabetes and their children are at an increased risk of
developing T2DM in the future. Women with gestational diabetes have 35 – 60% chance of
developing T2DM in the next 10 – 20 years while 5 – 10% of women with gestational diabetes
are found to have T2DM after pregnancy.5
Diabetes Mellitus (DM) is one of the primary causes of heart disease and stroke.
According to the Centers for Disease Control (CDC) Diabetes Report Card 2012, adults with
diabetes have 2- to 4-fold higher mortality rate for heart disease and 2- to 4-fold higher risk of
stroke. Hypertension is the most common co-morbidity associated with diabetes with around
67% of the adults with DM reported to have hypertension. Diabetes is also associated with other
complications such as blindness, kidney failure, gangrene and amputations of the lower limbs.5
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Type-2 Diabetes Mellitus (T2DM)
T2DM is a chronic metabolic disorder that affects over 25.8 million people in the US
with an estimated seven million people remaining undiagnosed.5 An alarming 79 million people
are reported to be in the pre-diabetes phase and have an increased likelihood of suffering from
diabetes in the future.5 T2DM is attaining epidemic proportions and in 2010 alone, 1.9 million
incident cases of diabetes were reported, almost three times as much in 1990.5 This sudden rise
in the incidence of T2DM is associated with an increase in obesity, decrease in leisure-time
physical activity, and aging population.5, 6 Diabetes was the sixth leading cause of death in the
US in 2002. In 2010 alone, 69,071 certificates listed diabetes as the underlying cause of death,
while it was mentioned as a cause of death in over 234,051 death certificates. The true extent of
the effect of diabetes, however, is likely to be underestimated as diabetes-related deaths are often
attributed to other causes.7 Studies show that diabetes was listed as a cause of death in 35 - 40%
of people with diabetes while only 10 -15% had it listed as the underlying cause of death.2, 7
Elevated blood glucose levels, a defining characteristic of diabetes, is associated with
increases in blood pressure and dyslipidemia. These lead to long-term complications such as
cardiovascular disease, diabetic neuropathy, diabetic retinopathy, kidney disease, gangrene and
amputation of lower limbs. These complications are primarily responsible for the increased
mortality and morbidity in patients with diabetes.7 The risk of death is approximately 2 times
higher in people with diabetes, as compared to those without it.7 Given the chronic nature of
diabetes, the economic impact associated with the disease is substantial. The total healthcare cost
for people with diabetes is 2.3 times higher compared to those without diabetes.6 In 2012,
diabetes (only diagnosed cases) cost the nation a total of $245 billion, of which $176 billion were
direct medical costs while $69 billion were due to loss in productivity.5 The American Diabetes
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Association (ADA) has predicted a significant rise in the number of people having diabetes in
the coming decades, which would further impose a huge burden on the allocation of healthcare
dollars.5
Diabetes Self-Management
‘Diabetes self-management (DSM),’ an essential component of diabetes care, is defined
as the ability to manage the symptoms, treatment, and lifestyle changes inherent in living with a
chronic condition.8 DSM involves modifying health behaviors (incorporate changes in daily plan
when necessary) to suit the treatment regimen and completion of self-care activities such as
following a regular diet and exercise plan, self-monitoring of blood glucose levels, and
adherence to medication.9 There is strong evidence linking DSM with optimal glycemic control,
enhanced quality of life and improved psychosocial functions.8 However, it is important to note
that DSM by itself is not sufficient in managing T2DM and the patients may eventually require
pharmacologic treatment(s) along with DSM to effectively manage and control their disease.
Diabetes complications such as obesity, gangrene, neuropathy (peripheral or autonomic),
retinopathy and poor renal function are often debilitating, costly, and could be fatal. These
complications are more common and more severe in patients whose diabetes is poorly controlled
(HbA1c > 7%). The term HbA1c refers to glycated hemoglobin, an index that clinicians use to
measure average blood sugar levels over a certain time-period. The normal HbA1c level for a
person without diabetes is 4 – 5.9%, for those who have diabetes, the target is around 6.5 – 7%,
and for those at a greater risk of hypoglycemia, it is 7.5%. The goal of DSM is to improve the
HbA1c control in individuals with diabetes and bring it closer to the optimal level (HbA1c ≤ 7).
The American Association of Diabetes Educators (AADE) has summarized evidence-based
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recommendations for DSM into the following behaviors: being active, eating healthy, taking
medications, blood glucose monitoring, problem solving (particularly in patients with high or
low blood glucose levels), reducing the risks for diabetes related complications and modifying
psychosocial behaviors to adapt to living with diabetes. In addition, the American Diabetes
Association (ADA) recommends weight loss or energy restriction, monitoring carbohydrate
intake, high fiber intake, limitation of saturated fat, trans-fat, cholesterol, and sodium and lastly,
consumption of fish twice a week. Diabetes care and management, and clinical preventive care
practices such as annual eye exams, annual foot exams, daily monitoring of blood glucose, and
diabetes self-management education (DSME), help control diabetes, thereby keeping people with
diabetes healthy. The management of diabetes requires coordinated medical care coupled with
patient self-management to decrease the risk of serious complications such as vascular, renal,
and ophthalmologic morbidities.10
Problem Statement
According to the 2003-04 State of Diabetes in America Report, only 33% of the patients
with diabetes achieved the American Association of Clinical Endocrinologists (AACE)
glycosylated hemoglobin level (HbA1c) target of <6.5%.6 Moreover, the proportion of patients
failing to achieve their target glucose levels appears to be rising. Patients who failed to achieve
the ADA target of HbA1c <7% increased from 55.5% during 1988 - 1994 to 64.2% during 1999
- 2000.2 It has been observed that these patients are likely to be non-responsive to their
treatments. Strong evidences have linked uncontrolled HbA1c levels to increased risk of
comorbidities such as diabetic neuropathy, retinopathy, CVD, and higher mortality rates.5 Failure
to achieve glycemic control is attributed to various patient factors such as lack of knowledge,
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comorbidities, financial resources (personal cost of care), non-compliance to therapy
(adherence), as well as physician-related factors such as beliefs, attitudes, knowledge,
communication with patients, type of health care system, and clinical inertia (inaction by
physicians to initiate or intensify therapy when indicated).11-19 Despite advances in treatment
options, an increasing number of patients fail to attain glycemic control. Evidence suggests that
the lapse in treatment failure and therapy advancement could be a factor responsible for these
unmet goals in disease management. Self-management of T2DM is a key element of the overall
management of the disease.9
Conceptual Framework
The overall study objective is to identify the barriers to self-management of diabetes in a
primary care setting and addressing these barriers using a theoretical framework. This is a crosssectional study of patients with T2DM and their physicians in a primary care setting in
Southwestern PA. The study employed a mixed method approach and combined the patient
survey data with the patient’s information extracted from their physician’s EMR database.
Responses from the patient survey were linked to different clinical outcomes available in the
EMR database. The EMR database includes data from patient records including demographics and
clinical diagnoses, procedures, laboratory test results, medication types and dosages, HbA1c levels,

lipid profile, BMI, office visits, and comorbidities. Physicians were administered a survey to
assess their perceptions of patient barriers and challenges in managing uncontrolled T2DM
patients. This study aimed to identify the barriers and facilitators to diabetes self-management
and determine the strength and direction of their predictive value over the metabolic control in
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these patients. The interrelationship of barriers and facilitators with each other were also
assessed.
Study Objectives
Few studies exist on improving diabetes self-management among patients. In addition,
views and practices of practitioners caring for these patients have received little attention. Thus,
the overall study objective is to identify the barriers to self-management of diabetes in a primary
care setting and addressing these barriers using a theoretical framework.
Specific aims
Aim 1: To identify patient perceived barriers and facilitators to diabetes self-management.
Aim 2: To assess patients’ readiness to change their diabetes self-management behavior.
Aim 3: To identify physician perceived barriers to diabetes self-management.
Aim 4: To explore physicians’ challenges to overcome the barriers to self-management.
Following identification of physician and patient barriers and challenges to diabetes selfmanagement, a pharmacist-initiated individualized approach to these barriers will be
conceptualized.
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Research Questions and Overall Hypothesis
Research Questions for Aim 1:
One aim of this study was to identify the barriers and facilitators to diabetes self-management
(DSM). Additionally, the objective was to explore which of these factors significantly predict
DSM in the study population.
Q1. Is there a relationship between HbA1c control and diabetes self-management questionnaire
(DSMQ) score for the study population?
 Hypothesis 1 – There is no association between HbA1c and DSMQ scores.
Q2. Is there a relationship between various barriers and facilitators (factors) and HbA1c control?
 Hypothesis 2 – There is no association between various factors and HbA1c control.
Q3. Is there a relationship between various barriers and facilitators (factors) and DSMQ scores?
 Hypothesis 3 – There is no association between various barriers and facilitators (factors)
and DSMQ scores.
Research Question for Aim 2:
Another aim of this study was to identify the differences in patients’ characteristics based on
their readiness to change their health behavior.
Q4. Is there a relationship between patient’s readiness to change (as measured by their scores on
the stages of change ruler) and their diabetes self-care behaviors such as DSM, knowledge,
attitudes and beliefs related to diabetes, and their demographic characteristics?
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 Hypothesis 4 – There is no association between patients’ readiness to change and their
diabetes self-care behaviors such as DSM, knowledge, attitudes and beliefs about
diabetes and their demographic characteristics.
Research Question for Aim 3:
Apart from assessing the patients’ perspectives about their diabetes self-care behaviors, the aim
was also to assess their physicians’ perceptions about their practice and what prevented their
patients from achieving optimal self-management.
Q5. Which physician-related factors that affect DSM were significant?
 Hypothesis 5 – No physician-related factors that affect DSM were found to be significant.
Research Question for Aim 4:
We aimed at exploring physicians’ challenges in improving their diabetes patients’ diabetes self–
management.
Q6. Are there any recurrent themes that emerge from the physician reported challenges in
addressing patient barriers?
 Hypothesis 6 – No recurrent themes emerge from the physician reported challenges to
address patient barriers.
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Significance of the Study
Identifying barriers and facilitators to self-management and addressing them is a critical
step in achieving improved health outcomes in T2DM. Existing literature focuses mainly on
patient factors and less so on physician factors or physician-patient interactions.20 A disconnect
between the patients’ and physicians’ perceptions, knowledge, and attitudes can cause confusion
and conflict, which may potentially lead to poor patient health outcomes.20 There is a need to
explore the factors responsible for the patient’s non-responsiveness to their therapy.
Additionally, better understanding of physician’s perceptions is needed to improve diabetes care
and to promote self-management in this patient group.
Another important factor that needs to be assessed during the identification of barriers
and facilitators is the patient’s readiness to change their health behaviors. The Trans-Theoretical
Model (TTM) of change assesses patients’ readiness to change their health behaviors, and
measures the continual progression of individuals through a series of stages. These stages are
pre-contemplation (not ready to change/ unaware of the problem), contemplation (realizing the
existence of problem, weighing its pros and cons), preparation (intending to act in a near future),
action (adopting new behaviors), and maintenance (sustaining new behavior to prevent
relapse).21 It is important to recognize the degree to which patients are reluctant to change and
then addressing their conviction systematically using a stepped care model. Interventions using
the TTM framework in combination with other strategies have resulted in improved outcomes in
previous studies. Another aspect of this model is ‘Self-Efficacy.’ As the patients progress
through the various steps in the model, they become more confident and self-sufficient in
managing their disease.21
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This study is the first to explore both primary care physicians’ and patients’ perceptions
about the barriers to self-management of T2DM in a primary care setting. Results from our
systematic review of literature suggest that diabetes management can be achieved best in a
primary care setting with an individualized approach to address the barriers to improved
outcomes. These barriers include but are not limited to patient-related barriers such as adherence,
attitudes and beliefs, knowledge, culture/ethnicity/language, financial resources, comorbidities,
and social support. Health care provider factors such as beliefs, attitudes and knowledge, patientprovider communication and interaction, and type of health care system were also identified as
potential barriers. Assessment of these barriers is an essential step in developing interventions
that are targeted at improving the health of patients with uncontrolled diabetes. Successful
development and implementation of effective interventions such as regular monitoring and
increased patient control on disease management can help improve their clinical outcomes as
well as the overall quality of life. A large proportion of patients with controlled diabetes (HbA1c
≤ 7%) will ensure reduction in the overall healthcare expenditure in diabetes as well.
When patients are unable to reach their specified HbA1c goal, the ADA recommends
several interventions. These may include intensifying the treatment regimen, identifying barriers
to adherence, and increasing frequency of patient contact.22 Prior studies have reported
improvements in patient’s glycemic control through pharmacist intervention. In particular,
physician-pharmacist collaboration has been shown to significantly improve glycemic control in
patients who did not reach their treatment goals with usual medical care.23 An intervention where
a pharmacist follows-up on the patient's self-monitored goals and assists them in identifying and
overcoming barriers can be implemented. Thus, the results from this study will serve as an
important resource to design and implement targeted patient interventions that help improve the
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health of the diabetes population and also enhance their quality of life. A follow-up to this study
could be to employ a pharmacist-based intervention to address the identified barriers, following
which a cost benefit analysis could be performed to examine whether the pharmacist-based
intervention is an economically viable option that can be implemented on a large scale.

12

CHAPTER 2: REVIEW OF LITERATURE
Limited data exists on improving diabetes self-management among patients with T2DM.
In addition, views and practices of primary care physicians caring for these patients have
received little attention. Thus, the overall study objective was to identify the barriers to selfmanagement of diabetes in a primary care setting from the perspective of both patients and
physicians.
Objectives of the Review
The goal of the review was to identify studies that have reported barriers and facilitators
to self-management of T2DM from the perspectives of patients and healthcare providers such as
physicians, nurse practitioners and/ or medical assistants, or both patients and healthcare
providers. The review also included studies that employed the Transtheoretical Model of
Change (Stages of Change Model) in identifying barriers and facilitators of self-management.
Further, articles exploring the relationship between these factors and self-management and/ or
glycemic control using a structural equation modeling (SEM) framework were also examined.
Methods
Search Strategy
A systematic literature search was conducted among peer-reviewed journals from year
1990 to year 2014 across electronic databases such as PubMed, Scopus, Google Scholar, and
CINAHL. The search was conducted in accordance with Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Figure 2.1).
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Figure 2.1: Schematic Presentation of Methodology and Search Criteria
11,828 articles identified through database
search: (PubMed (n = 4848), Google Scholar,
Scopus (n = 2685), ProQuest (n = 3,474),
Social Sciences Citation Index (n = 2019) and
Cinahl (n = 1487)

Excluded Articles: n =
10,213
Clinical trials, commentaries,
reports were excluded
Articles whose full text was
unavailable were excluded

1615 full text articles were screened
Excluded Articles: n = 1500
Studies that were
interventions, T1DM related
studies and studies unrelated
to the topic of interest were
excluded

115 full text articles were reviewed

Excluded Articles:
11 studies did not focus on
self-management
9 studies did not focus on
T2DM

Articles included for evaluation (n = 95):
54 studies on barriers to self – management:
Patients’ Perspectives
9 studies on barriers to self – management:
Physicians’ Perspectives
19 studies on barriers to self – management:
Patients’ & Physicians’ Perspectives
2 studies on Stages of Chance model in
assessing barriers to self – management
4 studies employing SEM to explore
relationships between various barriers/
facilitators to self – management

Articles included for evaluation (n
= 95):
39 qualitative studies using focus
groups
32 survey based studies
7 reviews
2 studies with EMR
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The search strategy included the following keywords and their combinations: Diabetes,
type 2 diabetes, self–management, self–care, barriers, facilitators, factors, clinical inertia,
stages of change, readiness to change, transtheoretical model of change. The search was
expanded by the identification of additional key search and MESH terms uncovered in the initial
review. Some searching on other databases, such as ProQuest and Social Sciences Index was also
fruitful, in identifying articles of interest. Bibliographies of identified articles were screened for
additional studies of relevance that may have been cited. The search was limited to studies
published in the English language. However, the search was not limited by geographic location
of the study population.
The aim of this search was:
1. To identify studies that assessed barriers and facilitators to diabetes self–management in
patients with T2DM from the perspectives of patients and/ or their health care providers
2. To explore studies that assessed health care providers’ challenges in addressing these
barriers
3. To evaluate studies that assessed changes in patient behavior based on the Stages of
Change Model
4. To identify studies that explored the relationships between various barriers and
facilitators to self–management and glycemic control in patients with T2DM
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Inclusion and Exclusion Criteria
Articles were included in the final review if they explored the barriers and facilitators to
DSM in T2DM population or explored the providers’ challenges in addressing these barriers.
Articles that evaluated the self-management behavior of patients with T2DM using a theoretical
framework were also included in the review. Studies focusing on T1DM or on interventions for
improving the self–management in patients with T2DM were excluded from the final review.
Randomized clinical trial studies that reported only clinical outcomes, articles that assessed nonpharmacological treatments, psychometric studies, conference abstracts, dissertations,
commentaries, editorials, or summary reports and review articles were excluded from the review.
Data Extraction
After applying the inclusion/exclusion criteria, the identified studies were further
subjected to extensive review in order to extract the relevant data. For studies assessing barriers
and facilitators to diabetes self- management, the following information was collected: barriers/
facilitators/ factors assessed, study population (patients/ health care providers), sample size,
socio-demographic variables (age, ethnicity and geographic location), study setting, methods and
key findings. Studies describing the instruments utilized to measure these factors were evaluated
for the type of scale utilized and their psychometric properties such as reliability and validity.
Data regarding the relationships between various patient and physician related factors associated
with diabetes self-management, using a SEM framework, was also collected.
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Results of Literature Search
1. Assessment of Barriers and Facilitators to Diabetes Self–Management:
Self-management plays an important role in the overall management of diabetes. A
number of psychological factors such as knowledge, adherence, readiness to change and
medication preferences contribute to the overall self-care behaviors of patients with T2DM.
Although knowledge of the disease is paramount in coping with the stress related to living with
diabetes and effectively managing it, it is not sufficient to bring about behavior change regarding
self-care management to achieve optimal glycemic control. Patient’s attitudes and beliefs also
play a significant role in influencing their overall self-care behaviors. Other factors such as
relational conflicts (disagreements or misperceptions in relations that lead to strong negative
thoughts), lack of social support, financial barriers, and access to health care could influence
patient’s self-management of diabetes. A deeper understanding of patient’s perspectives will
assist health care professionals to recognize his/her specific needs and devise treatment plans to
optimize the outcomes.24
The past two decades have seen a paradigm shift in the treatment of patients with
diabetes. Surprisingly, this time period has also witnessed an increasing number of patients
failing to achieve optimum glycemic control. These changes may have contributed to an
increased incidence of diabetes complications over time. Evidence shows that optimum glycemic
control can be achieved through early, aggressive management of diabetes.25 However, there are
several challenges to diabetes management. These include optimization of the use of treatment
options to ensure adequate glycemic control, blood pressure management and lipid control,
reducing the resulting complications, improving patient education on diabetes self-management
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and patient adherence to pharmacologic and non-pharmacologic interventions, reducing barriers
to insulin use and improving the delivery of health care.26 This review of literature focuses on
various barriers and facilitators to diabetes self-management and self-care behaviors in patients
with T2DM.
Patients’ Perspectives on Factors Contributing to Diabetes Self-Management
Seven standard self-management behaviors are identified by the American Association of
Diabetes Educators: Healthy eating habits, active lifestyle, regular monitoring of blood glucose,
medication adherence, problem solving for diabetes self-care related issues, healthy coping
mechanisms and reducing the risk factors of acute and chronic complications. However, several
barriers prevent the patients from performing these activities effectively. Identification of these
barriers and development and implementation of realistic self-management strategies marked by
collaborative alliances between patients and health care providers will ensure improved health
outcomes in this population.27 This section highlights patients’ perspectives of these barriers and
facilitators to diabetes self-management as elucidated in the literature search.
Self-efficacy is an important characteristic that influences patients’ self-care behaviors in
managing their diabetes. Rosenstock’s proposal of incorporating the attribute of self-efficacy of
patients in an expanded health belief model was corroborated by a study, which found that the
perceived barriers to self-efficacy were associated with poor self-care behaviors while a
perception of self-efficacy was associated with better adherence to self-care activities and
consequentially, improved outcomes.28A randomized control study evaluated the ‘superiority of
assessment of barriers to self-care and strategies to cope with these barriers’ over ‘usual care
with attention control’ in an elderly population with diabetes.29 It was found that diabetes-related
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distress was lowered by providing attention alone, but focused strategies to cope with barriers
employed by diabetes educators improved glycemic control and self-care frequency, and
maintained functionality in addition to lowering distress in this population.
Self-monitoring of blood glucose (SMBG) is considered one of the major components of
diabetes self-management since the results from Diabetes Control and Complications Trial
demonstrated the efficacy of intense glycemic control through insulin therapy and SMBG in
improving health outcomes.30 A study by Ong et al (2014) explored the barriers and facilitators
to self-monitoring of blood glucose (SMBG) in patients with T2DM dependent on insulin
through semi-structured individual in-depth interviews of 15 participants in Malaysia.31
Frustration regarding high HbA1c levels, stigma, fear of needles and pain, costs of test strip and
needles, inconvenience, unconducive workplace, and lack of motivation, knowledge and selfefficacy were identified as barriers in the study. The identified facilitators to SMBG were:
experiencing hypoglycemic symptoms; desire to see the effects of dietary changes; desire to
please the physician; and family motivation. The authors concluded that the health care providers
must take into account participant’s perceptions of the purpose of SMBG, the emotions
associated with SMBG, and the complexity, pain, and cost related to SMBG as well as personal
and family motivation, when counseling people with diabetes on SMBG. A cross-sectional study
explored similar barriers to SMBG in adults with diabetes in a Health Maintenance Organization
(HMO).32 They concluded that it is a difficult task to change the self-monitoring behavior of
patients with greatest risk for poor outcomes such as the elderly, minorities and those with lower
socioeconomic status.
An analysis of patient perceptions of barriers and facilitating factors to disease selfmanagement was performed using 12 focus group interviews of 70 patients with T2DM and
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hypertension in San Jose, Costa Rica and Tuxtla Gutierrez, Mexico.33 The analysis employed a
Transtheoretical Model of Change framework, where various barriers/ facilitators and themes
emerging from the focus groups were categorized into different stages of change namely precontemplation, contemplation, preparation, action and maintenance. Another study explored the
level of physical activity, barriers to physical activity and strategies employed to meet physical
activity goals in patients with T2DM using a Transtheoretical Model of change framework. This
study found out that patients who opted to work on physical activity participated in more general
and specific physical activity and had a higher stage of change for physical activity.34
Poor patient–healthcare provider relationship, inadequate education and psychosocial
problems were some of the themes identified in a qualitative study by Zamzam et al whose goal
was to assess barriers to diabetes control in Syrian women.35 The need to explore patient’s
psychological barriers was pointed out by another study that assessed the relationship between
depression, self-esteem, diabetes-care and self-care behaviors in a middle-aged Mexican
population.36 Barriers to medication adherence were explored in a poorly controlled diabetes
population by Odegard et al (2008) and they found that taking more than two doses of DM
medication daily and difficulty reading the diabetes medication labels were two factors that had a
significant association with higher HbA1c levels.37
The results from a study by Cox et al (2004) in low income African-American and
Caucasian adults with T2DM showed that best disease management is possible in patients with
high degree of knowledge of diabetes, positive attitudes, adherence to diet, and few perceived
barriers to physical activity. They also found that similar educational strategies can be
implemented effectively for patients with T2DM belonging to both races.38 However, another
study by Lynch et al (2012) focusing on racial differences between African American and
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Mexican American low income T2DM patients pointed out that several differences exist between
these races with respect to diabetes self-management and that an understanding of these
differences may facilitate development of effective self-management interventions in these high
risk populations.39 The need for improving diabetes self-management knowledge is also
underscored by a cross-sectional survey based study of 30 Puerto Rican adults with T2DM.40
A qualitative survey based study by Zgibor and Simmons (2002) explored the barriers to
blood glucose monitoring (BGM) in a multiethnic community.41 Following categories of barriers
to diabetes care were generated: Internal psychological (self-efficacy/health beliefs), external
psychological (psychosocial environment), internal physical (comorbidities/side effects of
treatment), external physical (finance/access to care) and educational (knowledge of
diabetes/services) barriers. The findings indicated that patients reporting both internal and
external psychological barriers and external physical barriers were unsuccessful at performing
BGM irrespective of their age, ethnicity, insulin use, sex, diabetes knowledge, and glycemic
control.
Depression is associated with a higher number of barriers to self-management in patients
with T2DM. This underscores the importance of depression screening and depression treatment
in these patients.42 Another important factor identified by Tiedt et al in a Native American
population was perceived unsatisfactory care, which served as a barrier to self-management.
Other barriers to self-management in this population were communication barriers (distrust,
misunderstanding, and educational methods) and organizational barriers (quality of care and
access issues).43 Interventions addressing these barriers should have cultural relevance and
incorporate family support and diabetes self-management skills education.44 Good social support
is a significant indicator of health promoting activities and overall well-being among patients
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with T2DM.45 Family support can play an important role in improving self-efficacy of patients
with diabetes and thus, improve their overall self-management adherence. On the other hand,
non-supportive behaviors by family members can influence the patients’ self-management
adherence negatively.46
In a study by Strauss et al (2006), driving distance was identified as an important barrier
to glycemic control in a population comprising of older, rural individuals.47 In patients whose
diabetes is resistant to the standard diabetes care and who persistently exhibit poor glycemic
control, strategies should selectively target those barriers responsible for this resistance.48, 49
Health Care Provider’s Perspectives on Factors Contributing to Diabetes Self-Management
A few studies have reported health care providers’ perspectives regarding selfmanagement in their patients with diabetes. A study by Scrambler and colleagues utilized indepth semi-structured interviews to explore health care professional’s opinions about the
opportunities and barriers in empowering patients with T2DM. The result showed that
empowerment of patients is beneficial for both, patients and Health Care Practitioners (HCPs).
However, there are some important barriers such as lack of resources, time and HCPs’ training in
patient empowerment, which the HCPs face in the clinical implementation of empowerment on a
daily basis. In patients who remain uncontrolled in a primary care setting, it has been suggested
that directing the patients to an endocrinologist or diabetes educators who focus on addressing
barriers to improving glycemic control may produce positive results.50 This can be achieved
through improved patient engagement. Intrinsic factors such as attitudes and health beliefs,
depression, self-efficacy, level of diabetes knowledge and technical skill, ethnic perspectives,
functional health literacy and medication adherence, impact patient engagement. In addition,
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patient engagement is affected by extrinsic factors such as financial capabilities, family
influences, workplace environment, community environment, clinical relationships and access to
effective diabetes healthcare delivery.
Carratala-Munuera and colleagues used Delphi technique to draw consensus between the
opinions of health care experts of T2DM on a 41-item questionnaire that explored barriers
associated with poor glycemic control in a Spanish population with diabetes.51 The study found
that non-compliance to therapy improved with a well-informed partner/ family/ caregiver, patient
education, motivation and the health care provider’s ability to share and agree on decisions with
the patients. Clinical Inertia, described as the lack of treatment intensification in a patient not at
evidence-based goals for care, was found to improve with motivation and education of the health
care professionals. It gets worse with lack of consultation time, missing data in medical records,
misinterpreting border high readings as normal, lack of treatment goals and teamwork between
physicians and nurse, scarcity of resources, and lack of alarm systems or flags in the EMR on
potential goals. The consensus was that interventions should focus on non-therapeutic
compliance and clinical inertia in order to improve glycemic control in patients with T2DM.
The need for continuous diabetes education for patients and healthcare professionals was
emphasized in a study by Sprague et al (2013), which assessed diabetes educators’ perspectives
on barriers affecting patient access to and utilization of diabetes education and its utilization.52 A
qualitative analysis of 25 Delaware physicians identified the following barriers to diabetes
management: a persistent orientation towards acute care, lack of patient based proactive patient
management, insufficient diabetes self-management education, poor integration of payer-driven
disease management activities, lack of available clinical information and public health support.
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These findings suggest that barriers like these limit the ability of primary care providers to
manage their patients with T2DM.53
Patient’s and Health care provider’s perspectives on Factors Contributing to Diabetes SelfManagement
A comprehensive assessment of patient barriers from both patient’s and physician’s
perspectives may aid in designing specific, measurable, achievable, relevant and time-bound
(SMART) interventions to address these barriers. The literature review yielded the following
studies that took into account both these perspectives. Nam et al (2011) published a review on
barriers to diabetes management with an objective of exploring both patient and provider
factors.20 They summarized the following patient factors that could affect self-management:
Adherence, attitudes and beliefs, knowledge of diabetes, culture and language capabilities, health
beliefs, health literacy, financial resources, co-morbidities and social support. They also
identified the following provider factors: Attitudes, beliefs and knowledge of diabetes and
patient- physician communication. Another review of barriers to self-management of diabetes by
Ahola et al (2012) observed knowledge, empowerment, health literacy, health beliefs, selfefficacy, coping, problem solving skills, locus of control, depression, fear of hypoglycemia, and
social support as the major patient barriers while physician-patient communication and
physician’s knowledge, beliefs and attitudes were noted as provider barriers.15
Shultz et al (2001) assessed the views of patients with T2DM and their diabetes educators
regarding barriers to diet and exercise, which are two of the essential components of diabetes
self-management.52 They employed cross–sectional mail survey design to gather information
from patients (n = 97) from three small regional hospitals from eastern Washington and diabetes
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educators (n = 147) from the Washington Association of Diabetes Educator (WADE). The
results indicated a difference in patients’ and diabetes educators’ perceptions regarding these
barriers, suggesting the need for focusing on barriers that may be specific to a given patient,
thereby providing an individualized approach to care. Beverly et al (2012) explored physicians’
and patients withT2DM’s views on their perceived responsibility and self-blame regarding
patients’ difficulty in achieving diabetes treatment goals.16 It was a qualitative study that
employed in-depth interviews with a semi-structured interview guide, of 19 endocrinologists and
primary care physicians and 34 patients with diagnosed T2DM. Physicians were reported to
accept responsibility for patients not achieving treatment goals and felt like they may not be
doing enough to help their patients. On the other hand, patients blamed themselves for not being
able to achieve the recommended goals. Both physicians and patients perceived that the other felt
frustrated and disappointed regarding unmet goals. The authors concluded that these factors may
act as barriers to an effective relationship between physicians and patients. A better
understanding of each other’s frustrations and challenges in management of diabetes may result
in improved outcomes in these patients and increased satisfaction in their physicians.
A total of 13 themes of barriers and facilitators to T2DM emerged in a study by Jones et
al (2013) who employed a cross-sectional qualitative study design through focus group (n = 8)
and telephone interviews of patients (n = 10), and telephone interviews with health professionals
(n = 18). These themes include interpersonal (stress and relationships), organizational (access to
recommended foods, transport, health professional, and exercise options) and societal
(engagement and social attitudes).54 Overall, the participants found it difficult to maintain
preferred management behaviors.
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A study by Renfrew et al (2013) conducted in Cambodia utilized focus group interviews
of health care providers, staff and patients with diabetes.55 The authors reported that certain
cultural beliefs, low health literacy, and language barriers strongly affected Cambodian patients’
understanding of diabetes and self- management, as well as clinicians’ ability to care effectively
for Cambodian patients with diabetes. Focus group interviews of 15 physicians and 37 patients
with T2DM conducted by Carbone et al (2006) assessed the physicians’ perceptions of patient
knowledge, attitudes and behaviors. Patient knowledge, beliefs, practices, barriers and
facilitators were also assessed.56 Findings indicated that the patients frequently had negative
thoughts about self-management while their religious beliefs and support of the practitioners
positively affected their self-management behaviors.
Wu et al (2014) examined the differences in perceptions of self-care, health education
barriers and educational needs between patients with DM and their nurses.57 A cross-sectional
survey based design was utilized in a convenience sample of 312 patients with T2DM and 202
nurses. The patients perceived that they performed self-care activities successfully while the
nurses perceived the patients to be inefficient in performing these tasks. The need for diabetes
education was highlighted by nurses more than patients and the nurses also perceived that the
patients my experience difficulties in diabetes health education more than the patients themselves
perceived.
A study by Piette et al (2003) highlighted the importance of patient physician
communication in improving diabetes self-management.58 Simmons et al (2007) found that
discordance exists in the perceptions of patients and healthcare professionals regarding the
importance of different barriers to diabetes care.12
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A multinational Diabetes Attitudes, Wishes and Needs (DAWN) study assessed the
psychological problems and barriers to improved diabetes management from healthcare provider
and patient perspective.59 Patients were found to rate themselves better at self-care activities in
comparison to their physicians. Most patients were found to have poor psychological well-being
as reported by the healthcare providers. Providers often lack the critical resources such as skill,
time and adequate referral sources to improve diabetes management through addressing these
barriers. The results from a South African study emphasized the need for patient-centered
approach to care in enhancing their knowledge of the disease and encouraging change in health
behaviors.
Summary
The articles in this review focused on several patient related factors that influence
diabetes self-management and glycemic control. Facilitators such as improved self-efficacy and
adherence, regular self-monitoring of blood glucose, positive attitudes, adherence to diet and
physical activity and family support and social support were identified. Barriers such as lack of
knowledge and motivation, frustration, stigma, poor physician – patient relationship and
comorbidities such as depression were also identified. The relationships between these factors
and diabetes self-management were explored using different tools such as focus groups and
semi-structured interviews. Health Belief Model and Transtheoretical Model of Change were
also employed in assessment of these relationships. In addition to the patient factors, several
physician-related factors were identified in the review, which included barriers such as lack of
time, resources and proper training of HCPs to empower patients, lack of motivation, poor
physician-patient relationship and clinical inertia. The findings of this review underscore the
need for a comprehensive assessment of the overall factors that influence/ affect diabetes self-
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management and glycemic control. Doing so will enable health care practitioners to design and
implement targeted interventions to improve health outcomes in patients with T2DM.
2. Instruments assessing various Barriers to self-management:
This section discusses various instruments assessing diabetes self-management or related
self-care activities that were identified in the literature review. Van Dijk-de Vries et al (2011)
developed ‘Health Promotion Diabetes’ (HEPRODIA) instrument to identify the needs of
patients with diabetes mellitus for activities that promote health through preferred change in their
lifestyle behavior.60 The study by Mollem et al (1996) attempted to assess perceived barriers to
self-care in insulin-dependent diabetes patients using Barriers in Diabetes Questionnaire
(BDQ).24 This instrument can serve as a valuable and reliable tool to find focus points for patient
education in different populations. On an individual level, BDQ can help explore patient’s
specific problems such as difficulty in injecting insulin at regular intervals before meals,
controlling the blood glucose levels, managing dietary requirements, and attitudes towards these
behaviors. Lin et al (2007) developed Diabetes Self-Management Instrument (DSMI) to measure
self-management of adults with T2DM.61 Cox ED et al developed and validated PRISM
(Problem Recognition in Illness Self-Management); an instrument that assesses barriers to selfmanagement in adolescents with DM.62 Factor analysis of the instrument identified the following
domains: Understanding and Organizing Care, Regimen Pain and Bother, Denial of Disease and
Consequences, and Healthcare Team, Family, or Peer Interactions. All these domains were found
to be significantly related to HbA1c. Another instrument, Diabetes Self-Management
Assessment Report Tool (D-SMART) collects information about patients’ behaviors and
identifies their priorities and barriers to change, thus providing valuable inputs for diabetes selfmanagement education (DSME). Abubakari et al (2011) assessed the factor structure and internal
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consistency of the Revised Illness Perception Questionnaire (IPQ-R) in a population with T2DM
and found its psychometric properties satisfactory.63 A modified 34-item model of IPQ-R by
Brzoska et al (2012) showed good reliability and validity in in assessment of illness perception in
a Turkish healthcare setting.64 Diabetes Self-Management Questionnaire (DSMQ) was designed
by Schmitt et al (2013) to assess the self-care activities that can predict glycemic control in
patients with DM.65 It demonstrated acceptable psychometric properties and has value in
scientific analyses as well as clinical use for this population. The Patient perceived Difficulty in
Diabetes Treatment (PDDT) scale is a 12-item questionnaire developed by Tamir et al (2012)
that measures the following characteristics: adherence to self-monitoring of glucose schedule,
frequency of self-monitoring of glucose, adherence to medication administration schedule,
frequency of medication administration, multiple number of medications, synchronization
between meals and medications, dependence on the medications, pain associated with treatment,
diet restrictions, self-care, multiple healthcare providers, and costs of treatment.66 This
instrument is a resource in identifying the potential barriers to adherence to treatment guidelines
and new treatment options. A 28-item Diabetes, Hypertension and Hyperlipidemia (DHL)
knowledge instrument assesses the knowledge of patients regarding these diseases and
medications.67 This instrument can be used to test the baseline patient knowledge of these
diseases and/ or determine the effectiveness of an educational intervention.
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Table 2.1: Instruments Assessing Barriers and Facilitators to Diabetes Self-Management
Abbreviation

Instrument

Items

Domains

Domain Description

Scaling and
Scoring

Administrati
on

Psychometric
Properties

HEPRODIA

Health Promotion
Diabetes

14
fixed

2

Intention to change
health care behavior,
Self-efficacy and needs
for support to
overcome obstacles (in
smoking cessation,
dietary behavior,
physical activity and
other health promoting
activities)

5 point
Likert scale
(Strongly
disagree to
strongly
agree)

Patients

Reliability:

NA

5 point
Likert scale
(very good
– very bad)

Patients

Self-integration, selfregulation, interaction
with health
professionals and
significant others, selfmonitoring of blood
glucose, adherence to
recommended regimen

4 point
Likert scale
(not relevant
to very
relevant)

Patients

Understanding and
Organizing Care,
Regimen Pain and
Bother, Denial of
Disease and

5 point
Likert scale
(Strongly
disagree to

Patients

4 – 20
variabl
e

BDQ

Barriers in Diabetes
Questionnaire

28

3

30

DSMI

PRISM

Diabetes SelfManagement
Instrument

35

Problem Recognition in
Illness SelfManagement

32

5

6

Cronbach’s α
= 0.46 to 0.74
Validity: Face
validity

Reliability:
Cronbach’s α
= 0.73
Validity:
Unknown
Reliability:
Cronbach’s α
= 0.94

Reliability:
Unknown
Validity:
Construct,

Consequences, and
Healthcare Team,
Family Interactions,
Peer Interactions
PDQ

Personal Diabetes
Questionnaire

68

13

31

D-SMART

Diabetes SelfManagement
Assessment Report
Tool

-

-

strongly
agree)

Perceived blood
Variable
glucose control, Weight scaling and
change readiness, Diet
scoring for
knowledge and skills, each domain
Diet change readiness,
Diet decision making,
Eating problems, Diet
barriers, Medication
use, Medication
Barriers, Blood glucose
monitoring, Blood
glucose monitoring
barriers, Physical
activity, Exercise
barriers
-

-

Discriminant,
Concurrent

Patients

Reliability:
Cronbach’s α
= 0.650 –
0.834
Validity:
Critetion

Patients

Reliability:
Test-Retest,
Inter item
consistency
Validity:
Face, Content,
Concurrent

IPQ-R

Revised Illness
Perception
Questionnaire

34

3

Psychological causes,
Biological risk factor
causes, External/ other
causes.

5 point
Likert Scale
(Strongly
agree to

Patients

Reliability:
Cronbach’s α
> 0.61 for
each subscale

strongly
disagree)
DSMQ

Diabetes SelfManagement
Questionnaire

16

5

Validity:
Factorial,
discriminant

Glucose management,
Dietary control,
Physical activity,
Healthcare use and
Sum scale

4 point
Likert Scale
(Applies to
me very
much – does
not apply to
me)

Patients

Reliability:
Cronbach’s α
> 0.6
Validity:
Factorial,
known group,
convergent

Patient perceived
Difficulty in Diabetes
Treatment scale

12

1

NA

5 point
Likert Scale
(Not
difficult at
all – very
difficult)

Patients

Validity:
construct,
discriminant

DHL

Diabetes, Hypertension
and Hyperlipidemia
Knowledge Instrument

28

5

Diabetes,
Hypertension,
Hyperlipidemia,
Medications and
General issues

True or
False,

Patients

Reliability:
Cronbach’s α
= 0.79

32

PDDT

Scoring
from 0 – 28,
converted to
percentage

Validity:
Content,
Discriminant

Abbreviations - HEPRODIA: Health Promotion Diabetes, BDQ: Barriers in Diabetes Questionnaire, DSMI: Diabetes Self-Management Instrument, PRISM:
Problem Recognition in Illness Self-Management, PDQ: Personal Diabetes Questionnaire, D-SMART: Diabetes Self-Management Assessment Report Tool,
IPQ-R: Revised Illness Perception Questionnaire, DSMQ: Diabetes Self-Management Questionnaire, PDDT: Patient perceived Difficulty in Diabetes Treatment
scale, DHL: Diabetes, Hypertension and Hyperlipidemia Knowledge Instrument

CHAPTER 3: METHODOLOGY
The objective of this study was to understand the perspectives of patients with T2DM and
their physicians regarding the barriers and facilitators to diabetes self-management. Prior
research has focused on patient- and physician-related factors separately. However, this study
was conceptualized to gain a comprehensive understanding of the perceptions of patients as well
as their physicians in a primary care setting, using a theoretical framework.
This chapter encompasses information on the research design, sampling methodology,
data collection and statistical analyses.
Research Design
The study utilized a cross-sectional design and was conducted in two groups – physicians
working in the Preferred Primary Care Physicians (PPCP) group (n = 39) and patients with
T2DM who maintained an active status in the PPCP database. A mixed method approach was
utilized in patients with T2DM and a combination of survey research and electronic medical
record (EMR) database analysis were used to identify barriers and facilitators to selfmanagement of T2DM. Responses from the patient survey were linked to selected clinical
outcomes available in the EMR database, which was useful in gaining additional information on
patients, and also validating some of the self-reported patient information from the patient
surveys. For the physician group, survey research was utilized to understand their perceptions of
patient barriers, and challenges they encounter in managing patients with uncontrolled T2DM.
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Data Sources
Electronic Medical Records (EMR) Database
An electronic medical record (EMR) can be defined as ‘a digital version of a paper chart
that contains all of a patient’s medical history from one practice’.68 An EMR is essentially an
electronic database for healthcare, with data recorded, developed, maintained, and/ or provided
by clinicians and providers in direct patient care (diagnosis and treatment). EMR offers several
advantages over paper based records, in that they allow the providers to track patient data over
time, help them identify patients who require screening and other preventive visits, help monitor
patients for parameters such as vaccinations or blood pressure readings, and finally help improve
the quality of care provided in their practice.68 Adoption of EMR has been initiated by several
integrated health providers in the US, such as Kaiser Permanente, Harvard Pilgrim Health
System, and the Department of Veteran Affairs. EMR captures important clinical information
from each patient visit and thus, enables measurement of clinical outcomes and resource
utilization for each patient. Bates et al. argued in favor of implementation of EMR in primary
care setting; they believed that primary care is at the center of all medical care and that providing
excellent primary care demands that providers have all the necessary information while
providing care.69 This information and all the decision support needs, they argued, can be made
available through EMRs. The vision statement of the National Alliance for Primary Care
Informatics reads:
“To provide all U.S. citizens with good quality, affordable health care, every primary
care provider must be given the opportunity of using an electronic ambulatory information
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system, including a fully functional electronic medical record and with ability to access needed
clinical information at the time and place of care.”69
The management of diabetes requires coordinated medical care coupled with patient selfmanagement to decrease the risk of serious complications such as vascular, renal, and
ophthalmologic morbidities. Our study focused on identifying the factors (barriers and
facilitators) that are associated with diabetes self-management in a primary care setting. In
addition to the self-management related behaviors of the patients, it was also of interest to
measure their clinical outcomes, and examine any association these outcomes may have with the
patient’s level of self-management. Clinical data was pulled from the GE Centricity EMR
database utilized by PPCP group. The database contains data from 2010-2014 of over 7,000
active patients receiving care from 39 primary care providers in Southwestern Pennsylvania. The
EMR data constitutes longitudinal patient data that includes patient demographics and clinical
diagnosis, prescribed medications, procedures and laboratory tests. The PPCP group provided the
required data from EMR for the purpose of study analysis.

35

Patients
Identification of Patient Sample
Patients were identified from the EMR database of the PPCP group. Patients >18 years,
having 2 or more visits to their physicians (01/01/2012 to 12/31/2013) with a recorded diagnosis
of T2DM (ICD-9-CM: 250.xx) were identified in the EMR database. From the EMR sampling
frame of 7,000+ adult patients with T2DM, a random stratified sample of 2,100 patients was
drawn. The stratification technique involved creating three different strata of patients based on
their HbA1c levels: ‘Well Controlled’ (HbA1c < 7), ‘Moderately Uncontrolled’ (7 < HbA1c > 9)
and ‘Severely Uncontrolled’ (HbA1c > 9), and then randomly choosing 700 patients from each
strata. We retrieved information such as the patient names, addresses, and patient unique ID for
our mailing purposes from the PPCP office. All patient records were assigned unique patient IDs,
which were utilized to link the patient survey responses to the patient records in the EMR
database so as to extract selected clinical information such as comorbidity, HbA1c, LDL, and
diabetes medications. To ensure anonymity of the respondents, each patient in the sample was
assigned a unique code corresponding to the patient’s unique ID before mailing out the surveys.
All the identifying information such as patient name, address, and unique ID were deleted after
mailing out the surveys. EMR data was extracted by PPCP group for those patients who
responded to the surveys (n = 210).
Patient Survey
The patient survey was designed to collect information about the patients’ demographic
characteristics, their knowledge of diabetes, attitudes and health beliefs, level of selfmanagement, and their readiness to change health related behaviors. Standardized instruments
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with acceptable psychometric properties were employed to collect this information. These
instruments include Diabetes Self-Management Questionnaire (DSMQ) to measure DSM related
behavior, Revised Illness Perception Questionnaire (IPQ -R) to measure attitudes and beliefs
towards diabetes, Readiness to Change Ruler to assess their willingness to change health related
behavior, and Medication Preference Scale to identify patient preference for oral medications
and insulin. In addition, clinical information such as the patient’s most recent HbA1c level was
also collected through the patient survey.
Description of Patient Survey Instruments
The standardized instruments included in the patient survey are summarized below.
These instruments were selected as they demonstrated acceptable psychometric properties
(reliability and validity) and measured the variables of interest. Permission for use of these
instruments in this study was sought and received from the authors of the respective instruments.
1. Diabetes Self-Management Questionnaire (DSMQ)
Diabetes Self-Management Questionnaire (DSMQ) is a 16-item questionnaire that
assesses the level of self-management in patients with T2DM. It consists of the following
subscales: ‘Glucose Management’ (GM: items 1, 4 6, 10 and 12), ‘Dietary Control’ (DC: items
2, 5, 9 and 13), ‘Physical Activity’ (PA: items 8, 11 and 15), and ‘Health-Care Use’ (HU: items
3, 7 and 14), as well as a ‘Sum Scale’ (SS: item 16) as a global measure of self-care. The
questionnaire consists of some items that are worded negatively to minimize respondent bias.
Higher score represents more effective self-care. The scale scores are calculated by summing the
individual item scores and transforming it to a scale ranging from 0 to 10 (raw score/ theoretical
maximum score * 10). (Refer Table 3.1)
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2. Diabetes Instrument
The diabetes subsection of the Diabetes, Hypertension and Hyperlipidemia (DHL)
instrument was utilized to assess the patient knowledge of diabetes. It consists of 10 questions
with true or false type response. Each correct answer gives 1 point to the respondent and a wrong
answer gives 0 point. A higher score indicates higher diabetes knowledge. (Refer Table 3.2)
3. Revised Illness Perception Questionnaire (IPQ–R)
IPQ-R is a 34-item questionnaire that assesses the attitudes and health beliefs of patients
with T2DM. The questionnaire consists of a 5-point Likert scale type response with 1 being
‘strongly agree’ while 5 being ‘strongly disagree’. The following domains are identified in IPQR: Timeline (acute/ chronic), Consequences, Personal control, Treatment control, Illness
coherence, Timeline cyclical, and Emotional representations. Some items are negatively worded
to minimize respondent bias (Refer Table 3.3).
4. Readiness to Change Ruler
The Readiness to Change Ruler is a 5-point Likert scale that assesses the patients’
willingness to change their health related behaviors. The scoring on this ruler is based on the
Stages of Change Model. A score of ‘1 = Pre-contemplation (I do not think about changing my
diabetes self-management behavior)’, ‘2 = Contemplation (I think about changing my diabetes
self-management behavior)’, ‘3 = Preparation (I have decided to change my diabetes selfmanagement behavior)’, ‘4 = Action (I am already trying to change my diabetes selfmanagement behavior)’ and ‘5 = Maintenance (my diabetes self-management behavior has
changed. I manage my diabetes efficiently)’. (Refer Figure 3.1)
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5. Medication Preference Scale
This scale gathers information about the patients’ preferences for medications. It’s a 2item, 10-point Likert scale seeking preference for insulin and other injectable preparations as
well as for oral hypoglycemic agents, with responses ranging from 1: ‘not willing at all’ to 10:
‘totally willing’. (Refer Figure 3.2)
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Table 3.1: Diabetes Self-Management Questionnaire (DSMQ)
Sr INSTRUCTIONS: The following statements describe
(3)
(2)
(1)
. self-care activities related to your diabetes. Thinking Applie Applie Applie
N about your self-care over the last 8 weeks, please s to me s to me s to me
o. specify the extent to which each statement applies to
very
to a
to
you. Please answer the questions carefully. All much consid
some
responses will be kept confidential.
erable degree
degree
1. I check my blood sugar levels with care and attention



 Blood sugar measurement is not required as a
part of my treatment
2. The food I choose to eat makes it easy to achieve



optimal blood sugar levels
3. I keep all doctors’ appointments recommended for my



diabetes treatment
4. I take my diabetes medication (e.g. insulin, tablets) as



prescribed
 Diabetes medication/ insulin is not required as
a part of my treatment
5. Occasionally I eat lots of sweets or the other foods



rich in carbohydrates
6. I record my blood sugar levels regularly (or analyze



the value chart with my blood glucose meter)
 Blood sugar measurement is not required as a
part of my treatment
7. I tend to avoid diabetes-related doctors’ appointments



8.
9.
10
.

11
.
12
.
13
.

I do regular physical activity to achieve optimal blood
sugar levels
I strictly follow the dietary recommendations given
by my doctor or diabetes specialist
I do not check my blood sugar levels frequently
enough as would be required to achieve good blood
glucose control
 Blood sugar measurement is not required as
part of my treatment
I avoid physical activity, although it would improve
my diabetes
I tend to forget to take or skip my diabetes medication
(e.g. insulin, tablets)
 Diabetes medication/ insulin is not required as
a part of my treatment
Sometimes I have real ‘food binges’ (not triggered by
hypoglycemia)
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(0)
Does
not
apply
to me


























































14
.
15
.
16
.

Regarding my diabetes care, I should see my medical
practitioner(s) more often
I tend to skip planned physical activity

















My diabetes self-care is poor
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Table 3.2: Diabetes, Hypertension and Dyslipidemia (DHL) Questionnaire
Item
Question
True
1.
Diabetes occurs in people with insufficient or no

insulin
2.
As long as a diabetic person’s fasting blood sugar

level in the morning is in the normal range, he/she
can eat anything for that day
3.
Diabetes can be cured after taking medicines for a

period of time
4.
If the blood sugar level is high for long period of

time, it may cause other health problems such as
blindness
5.
Normal fasting blood sugar is between 70-130 mg/dL

6.
There is no problem for our blood pressure to remain

high as long as we do not feel sick
7.
Blood pressure of 140/90 mmHg and above is

considered as high
8.
If not treated, high blood pressure can lead to kidney

damage
9.
We can feel whether our blood pressure is high or not

10.
Diabetic people can eat as much fruits (such as

banana, papaya, orange, water melon) as they like
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False











Table 3.3: Revised Illness Perception Questionnaire (IPQ-R)
Sr.
Question
No.

Response
Strongly
Agree

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31
32.
33.
34.

My illness will last a short time
My illness is likely to be permanent rather than temporary
My illness will last a long time
This illness will pass quickly
I expect to have this illness for the rest of my life
My illness will improve in time
My illness is a serious condition
My illness has major consequences on my life
My illness does not have much effect on my life
My illness strongly affects the way other see me
My illness has serious financial consequences
My illness causes difficulties for those who are close to me
There is a lot I can do to control my illness
What I do can determine whether my illness gets better or
worse
The course of my illness depends on me
Nothing I do will affect my illness
I have the power to influence my illness
The negative effects of my illness can be prevented by my
treatment
Treatment can control my illness
There is nothing that can help my illness
The symptoms of my illness are puzzling to me
My illness has no meaning to me
I don’t understand my illness
My illness doesn’t make any sense to me
I have a clear picture or understanding of my illness
The symptoms of my illness change from day to day
My symptoms come and go in cycles
I go through cycles in which my illness gets better and worse
I get depressed when I think about my illness
When I think about my illness I get upset
My illness makes me feel angry
My illness does not worry me
My illness makes me feel anxious
My illness makes me feel afraid
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Strongly
Disagree

1
1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5
5
5
5
5
5

1
1
1
1

2
2
2
2

3
3
3
3

4
4
4
4

5
5
5
5

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5

Figure 3.1: Readiness to Change Ruler
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Figure 3.2: Medication Preference Scale:
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Patient Survey Administration
A mail survey was utilized for collecting patient data. In accordance with the Health
Insurance Portability and Accountability Act (HIPAA), patients were mailed a consent form at
the time of study enrollment informing them of the use of their medical information for research
purposes and requesting their voluntary participation. The participants were also mailed a cover
letter describing the study, the questionnaires, and a self-addressed reply envelope. The survey
administration was conceptualized in accordance with the Dillman Total Design Survey Method,
which requires the survey population to be administered with the questionnaire booklet, which
should be fewer than 12 pages.70 The Dillman method requires four mailings (including a followup post card) and a non-response survey for those who did not respond to any of the mailings.
Due to financial constraints (cost of survey and mailing charges), this study utilized a one-time
mailing. A nonresponse analysis was conducted by comparing early to late responders since
research has shown that late responders have characteristics similar to non-responders. In this
study, the initial surveys were sent out in accordance with the Dillman Method but due to limited
funding, follow up surveys and reminder post cards were not mailed. However, the responses
received from the single mailing were enough to be able to conduct the proposed analyses.

46

Patient Variables Extracted from Survey Report and EMR Database
Age
Age was reported by the participants through the surveys. It was measured in years and
categorized as 18 – 40 years, 41 – 50 years, 51 – 60 years, 61 – 70 years and ≥ 71 years. The
survey reported age was validated from the age variable found in the EMR database.
Gender
The gender variable was used as the indicator of sex. This variable was also validated using the
EMR database.
Ethnicity
For the purpose of analysis, this variable was categorized as Caucasian, African-American,
Asian, Hispanic and Others. This variable was also reported in the EMR database.
Education (survey reported)
This variable records the educational status of the participants in the following groups: less than
high school, high school/ vocational/ technical/ G. E. D. (General Educational Development),
some college, college and graduate.
Marital Status (survey reported)
This variable measured the marital status of the participants as currently married, divorced/
separated, widowed and never married.
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Yearly Household Income (survey reported)
For the purpose of analysis, the yearly household income of the participants was recorded as less
than $25,000, $25,001 - $50,000, $50,001 - $75,000, $75,001 -$100,000 and greater than
$100,000.
Insurance Type
We were interested to know if insurance status had any effect on the patient’s self-management
behaviors and HbA1c control. The variable ‘Insurance Type’ was used to identify the type of
Insurance coverage that the participants received and was categorized into the following:
Medicare, Medicaid, private, self-paid, uninsured and other.
Employment Status (survey reported)
The employment status of the participants was recorded through the patient survey as full time,
part-time, retired and not employed.
Years since Diagnosis of Diabetes
This variable measures the number of years for which the participants have been diagnosed with
T2DM. This information was validated using the diagnosis date obtained from the EMR
database.
Recent HbA1c Level
This variable measures the most recent self-reported HbA1c reading of the participants. This
value was matched to the entry in their EMR records.
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Smoking Status (survey reported)
The smoking status of the participants was categorized into 3 groups: non-smoker (a person who
has no history of smoking), former smoker (a person with a history of smoking, but is currently a
non-smoker) and current smoker (a person who currently smokes).
Co-morbidities
This variable assesses the number of comorbidities the participants have a diagnosis for such as
cardiovascular diseases (angina, heart attack, cardiovascular surgeries), hypertension, poor renal
(kidney) function, peripheral neuropathy, autonomic neuropathy, retinopathy, amputation,
depression, anxiety, obesity and gangrene (dead tissue).
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Physicians
Identification of Physician Sample
The physicians of the PPCP group were administered with a survey to gather information
on their perceptions of patient barriers and their own challenges in addressing these barriers. The
PPCP group consists of 39 physicians, who were all eligible for inclusion in the survey sample.
Physician Survey Administration
The physician survey was administered at a monthly meeting of the PPCP group. A total
of 24 responses were collected of which three responses were from medical staff members. Since
the perceptions of physicians who were directly involved in managing patients with T2DM were
being assessed, the staff responses were not included in the analysis giving a final sample of 21
physicians.
Physician Survey
The physician survey utilized both open- and closed-ended questions. Specifically, the
questions probed how important and difficult the physicians perceived self-care activities was for
their patients including regular moderate exercise, following a recommended diet, regular blood
glucose testing, proper insulin administration and adherence to oral medications. The survey also
asked the physicians about the proportion of their patients they believed were adherent to these
self-care activities. Additionally, the study evaluated how important the physicians believed
aspects of their practice such as physician-patient communication, patient health literacy and
patient follow-up and how the physicians rated their performance on these measures and how
satisfied they were with their performance. There was an interest in knowing the challenges
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physicians encountered in managing their patients whose HbA1c levels are uncontrolled (HbA1c
> 7); this data was collected using an open-ended question. Recurrent themes were identified
using techniques suggested by Ryan and Bernard (repetitions, cutting and sorting, similarities
and differences). Demographic information related to the physicians and their practice was
collected in the survey.
Description of Physician Survey Instruments
The objective of the physician survey was to identify the
1. Demographic characteristics of the physician practices such as its location (urban/ rural),
availability of staff support, and so on
2. Information about the physician’s age, years in practice, number of T2DM patients
examined per week and so on
3. The physicians’ perceptions about their patients’ self-management behaviors and their
practice’s performance in improving self-management in their patients
4. The barriers that contribute to clinical inertia (physician’s inability to intensify treatment
to help patients reach their unmet goals of care) in these physicians
The questionnaire was examined for its face validity and content validity through expert
opinions (opinions of investigators, PPCP physicians and PPCP pharmacist) about whether the
items in the questionnaire measure the above objectives adequately and completely. The items
which seemed not useful were removed from the questionnaire and those that received consensus
among the experts were included in the final questionnaire.
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Physician Related Variables
Demographic Information
Age
This variable measures the age of the participating physicians in years.
Gender
The gender variable was used as an indicator of sex of the Physicians
Years in Practice
This variable records the number of years the physicians have spent in diabetes practice.
Patients /Week
This variable records the average number of patients with T2DM, the physicians examine per
week.
Reasons for Referral
This variable enquires about the physicians’ reasons for referring the patients uncontrolled on
T2DM to endocrinologists.
Location
The location variable identifies the physician practice as rural or urban.
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Staff Support
This variable seeks information about the type of staff support available in the physician
practice: Nurse, Pharmacist, Others or None.
Variables Assessing Physician Perceptions
An important goal of the physician survey was to understand physician’s perceptions
about the importance and level of difficulty of various self-care activities in their T2DM patients.
The study also aimed to assess the proportion of patients the physicians believed were adherent
to different self-care activities. The study also sought to understand the physicians’ perceptions
about the importance of practice-related measures such as physician-patient communication,
patient health literacy and patient follow-up. There was an interest in measuring how the
physicians rated their performance on these measures and how satisfied they were with their
performance. The physician survey also measured the challenges these physicians encounter in
managing their T2DM patients through an open-ended question. The following variables were
used to collect this information:
Importance (Self-Care Activities)
This variable assesses physician perceived importance of performing diabetes self-care activities
such as regular moderate exercise, following a recommended diet, regular blood glucose testing,
proper insulin administration and adherence to oral medication, using a 5-point Likert scale.
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Difficulty (Self-Care Activities)
This variable assesses physician perceived difficulty in performing diabetes self-care activities
such as regular moderate exercise, following a recommended diet, regular blood glucose testing,
proper insulin administration and adherence to oral medication, using a 5-point Likert scale.
Adherence (Self-Care Activities)
This variable assesses physicians’ perceptions about the proportion of their patients adhering to
diabetes self-care activities such as regular moderate exercise, following a recommended diet,
regular blood glucose testing, proper insulin administration and adherence to oral medication,
using a 5-point Likert scale.
Importance (Physician Practice Factors)
This variable assesses physician perceived importance of practice related factors such as patientphysician communication, patient health literacy and patient follow-up, using a 5-point Likert
scale.
Performance (Physician Practice Factors)
This variable assesses the physicians’ perceptions of their performance on practice related factors
such as patient-physician communication, patient health literacy and patient follow-up, using a 5point Likert scale.
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Satisfaction (Physician Practice Factors)
This variable assesses the physicians’ satisfaction with practice related factors such as patient –
physician communication, patient health literacy and patient follow-up, using a 5-point Likert
scale.
Face-to-Face Interaction
This variable collects information about the average number of face-to-face interactions the
physicians have with their T2DM patients in a 3-month interval.
Follow-Up
This variable collects information on the number of times the physicians follow up with their
patients between any two face-to-face visits.
Reasons for No Follow up
This variable enquires about the various reasons that are responsible for patients not seeking
follow-up care.
Responsibility of failure
This variable records the extent to which the physicians feel responsible for their patients’ failure
to achieve their self-management goals using a 4-point Likert scale.
Challenges
This variable gathers information about the challenges faced by Physicians in managing their
patients with T2DM, using an open-ended question: “Please list the 5 most important barriers
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responsible for clinical inertia n your practice.” Clinical inertia is defined as the lack of treatment
intensification in patients who are not on evidence based goals for care.
Institutional Review Board (IRB) Approval
The proposed study was conducted in accordance with the Institutional Review Board
policies and procedures of Duquesne University. The study attempted to link the data collected
from surveys to the patients’ clinical data, as obtained from their electronic medical records.
Additionally, this study also probed the primary care physicians of these patients regarding their
beliefs about their practice. Given the nature of the proposed study, an expedited review was
approved by Duquesne University Institutional Review Board.
Informed Consent
The patients in the sample were mailed an informed consent form at the time of study
enrollment, informing them of the use of their medical information for research purposes and
requesting their voluntary participation. To ensure confidentiality, patients who responded were
tracked by the Principal Investigator (PI) using a code that was linked to the patient’s unique
patient ID. The survey data from the patients did not contain any identifying information except
for the code corresponding to their unique patient IDs which were used to link the survey data
with the EMR data extract. The primary care physicians in the practice also had to provide an
informed consent prior to participating in the study.
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Statistical Analysis Plan
The statistical analyses for this study were performed using IBM SPSS Statistics 23
software package. Two separate datasets were created from the patient survey and physician
survey respectively. The analysis plan for the study objectives is described below:
Patient Survey
One aim of this study was to identify the barriers and facilitators to diabetes selfmanagement (DSM). Additionally, the objective was to explore which of these factors
significantly predict DSM in the study population. Descriptive statistics were conducted for
patient characteristics. Correlation between the variables that were both collected through patient
survey and EMR database was reported using Cronbach’s α. Means and standard deviations were
reported for continuous variables such as age. Frequencies and percentages were reported for
categorical variables such as gender, marital status, level of education, race, insurance status, and
so on. Some continuous variables such as age, HbA1c level and BMI (captured from EMR
database) were converted to categorical variables to conduct appropriate analyses. Univariate
regression models were run to study the impact of various study variables on DSMQ score and
HbA1c level. Based on the results of the univariate regression analyses, significant predictors
were entered in multinomial regression models, to identify a set of predictors that best predict
HbA1c levels and DSMQ scores in these patients. Another aim of this study was to identify the
differences in patients’ characteristics based on their readiness to change their health behavior.
Univariate analyses were conducted to identify a set of predictors that best predict the patients’
readiness to change their health care behaviors.
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Physician Survey
Apart from assessing the patients’ perspectives about their diabetes self-care behaviors,
an aim of this study was to assess their physicians’ perceptions about their practice and about
what prevented their patients from achieving optimal self-management. Descriptive statistics
were conducted to report the characteristics of the responding physicians and their practices.
Means and standard deviations were reported for continuous variables such as age and years in
practice. Frequencies and percentages were reported for categorical variables such as physicians
feeling responsible for patient’s failure to reach self-management goals. Physicians’ perceptions
about their patients’ self-management behaviors and their beliefs about their practices were also
summarized. A qualitative component of the physician survey probed the physicians regarding
the challenges they face in improving their diabetes patients’ self-management. Recurrent themes
were identified using techniques suggested by Ryan and Bernard (repetitions, cutting and sorting,
similarities and differences) and the most common themes were reported.71
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CHAPTER 4: RESULTS
The primary aims of this study were to identify patient perceived barriers and facilitators
to diabetes self-management, to assess patients’ readiness to change their diabetes selfmanagement behavior, to identify physician perceived barriers to diabetes self-management and
to explore physicians’ challenges to overcome the barriers to self-management. This chapter
provides an overview of the study findings.
Patient Survey
Survey Administration and Response Rate
In order to collect the information about patient perceived barriers and facilitators to
diabetes self-management, a one-time mail survey was administered to a random stratified
sample of 2,100 patients. The survey was mailed on June 06, 2014 and the survey responses
were collected over the next three months. A total of 210 responses (10% response rate) were
received of which 161 responses (76.7%) were received within the first two weeks of survey
administration (early responders) while 49 responses (23.3%) were received after two weeks of
survey administration (late responders). The 10% response rate is lower than the average
response rate for patients with T2DM as found in the literature (around 40%). The low response
rate could be attributed to the absence of multiple mailings as per Dillman method and
appropriate incentives. 23 Despite the low response rate, a sample size (n = 210) was sufficient to
conduct all the proposed analyses.
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Nonresponse bias analysis:
We examined if early responders of the patient survey differed from late responders with
respect to their characteristics. Late responders typically have characteristics similar to nonresponders and it is important to assess if there is any non-response bias due to low response rate.
82, 83

It was found that early responders did not differ significantly from late responders with

respect to the any patient characteristic or self-care behavior, with the p-value set at 0.05 thereby,
increasing the confidence in the responses received (refer Table 4.1).
Objective 1: To identify patient perceived barriers and facilitators to diabetes self-management
Demographic characteristics
Table 4.2 presents the demographic and clinical characteristics of the respondents. The
respondents were predominantly Caucasians (93.80%), married (60%) and the sample consisted
of 108 males (51.4%). The respondents’ age ranged from 24 years to 88 years (mean age= 63.68
+ 11.79 years). A majority of respondents (55.70%) were in the 55-75 years’ age group. 17
respondents did not report their age. Age of the respondents was also collected from their
electronic medical records (EMR) which was consistent with the age reported by the patients in
the survey. Interestingly, age was missing for 6 respondents in their EMR as well. A sizable
proportion of the respondents (53.4%) had at least some college education.
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Table 4.1: Baseline Characteristics of Patient Sample (Stratified by Response Status)
Characteristics
Total Sample
Early
Late
P Value
Responders
Responders
(N= 210)
(N=162)
(48)
N (%)
N (%)
N (%)
63.7 (11.7)
63.1 (11.5)
65.6 (12.3)
Mean age (SD)
< 0.09
Age Group
46 – 55 Years
41 (21.2)
36 (24.3)
5 (11.1)
56 – 65 Years
64 (33.2)
50 (33.8)
14 (31.1)
> 65 Years
88 (45.6)
62 (41.9)
26 (57.8)
0.23
Gender
Male
108 (51.4)
87 (53.7)
21 (43.7)
Female
102 (48.6)
75 (46.3)
27 (56.3)
< 0.01*
Ethnicity
Caucasian
197 (95.2)
154 (96.3)
43 (91.5)
African-American
5 (2.4)
5 (3.1)
0 (0.0)
Asian
2 (1.0)
0 (0.0)
2 (4.3)
Other
3 (1.4)
1 (0.6)
2 (4.3)
0.28
Education
High school/ vocational
97 (46.4)
73 (45.3)
24 (50.0)
College or Some College
74 (35.4)
55 (34.2)
19 (39.6)
Graduate
38 (18.2)
33 (20.5)
5 (10.4)
0.93
Marital Status
Currently Married
126 (60.3)
99 (61.5)
27 (56.3)
Divorced/ Separated
32 (15.3)
24 (14.9)
8 (16.7)
Widowed
31 (14.8)
23 (14.3)
8 (16.7)
Never Married
20 (9.6)
15 (9.3)
5 (10.4)
0.92
Yearly Income
≤ $25,000
58 (30.7)
47 (31.8)
11 (26.8)
$25,001 - $50,000
54 (28.6)
43 (29.1)
11 (26.8)
$50,001 - $75,000
33 (17.5)
24 (16.2)
9 (22.0)
$75,001 - $100,000
21 (11.1)
16 (10.8)
5 (12.2)
> $100,000
23 (12.2)
18 (12.2)
5 (12.2)
< 0.5
Insurance
Medicare
107 (52.5)
79 (50.6)
28 (58.3)
Medicaid
9 (4.4)
8 (5.1)
1 (2.1)
Private
66 (32.4)
49 (31.4)
17 (35.4)
Self-Paid
6 (2.9)
6 (3.8)
0 (0.0)
Other
15 (7.4)
1 (0.6)
0 (0.0)
0.62
Employment
Full – Time
53 (25.7)
40 (25.3)
13 (27.1)
Part – Time
15 (7.3)
13 (8.2)
2 (4.2)
Retired
114 (55.3)
85 (53.8)
29 (60.4)
Unemployed
24 (11.7)
20 (12.7)
4 (8.3)
0.41
Smoking
Current Smoker
18 (8.7)
15 (9.5)
3 (6.3)
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Former Smoker
Non-Smoker
Referral to an
Endocrinologist
Yes
No
Comorbidities
Cardiovascular Disease
Hypertension
Renal Failure
Peripheral Neuropathy
Retinopathy
Depression
Anxiety
Obesity

72 (35.0)
116 (56.3)

58 (36.7)
85 (53.8)

14 (19.4)
31 (64.6)
0.93

56 (27.7)
146 (72.3)

43 (27.6)
113 (72.4)

13 (28.3)
33 (71.7)

57 (27.1)
156 (74.3)
14 (6.7)
39 (18.6)
26 (12.4)
50 (23.8)
43 (20.5)
62 (29.5)

44 (27.2)
120 (74.1)
8 (4.9)
30 (18.5)
20 (12.3)
36 (22.2)
32 (19.8)
49 (30.2)

13 (27.1)
36 (75.0)
6 (12.5)
9 (18.8)
6 (12.5)
14 (29.2)
11 (22.9)
13 (27.1)

Chi square test were used with significance level set at p < 0.05.
* Significant associations
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0.17
0.90
0.19
0.97
0.51
0.48
0.63
0.67

The yearly household income of 53.5% respondents was under $50,000; 32.3% of the
respondents were employed, 54.3% were retired, and 11.4% were unemployed. The respondents
greatly varied in the number of years since their first diagnosis of diabetes. The duration ranged
from 1 to 60 years with a mean duration of 13.03 ± 9.749 years. Over half of the respondents
(55.2%) were non-smokers. A total of 107 patients (51%) were insured with Medicare while 71
patients (33.8%) patients reported more than one source of insurance.
The patient survey also assessed patients’ clinical attributes such as the comorbidities,
latest HbA1c level and if the patients received any referrals to an endocrinologist by their
primary care physician. Majority of respondents had comorbid hypertension (74.3%) and some
other major comorbid conditions included obesity (29.5%), cardiovascular (27.1%), depression
(23.8%) and anxiety (20.5%). 27.7% of the respondents were referred to an endocrinologist by
their primary care physician.
The HbA1c levels of the respondents ranged from 4.5 to 14.0 with a mean of 7.83 ± 1.69.
A total of 59 survey respondents (28.10%) did not report their HbA1c level. The challenges of
missing data or self-reports were overcome as HbA1c data was also collected from the EMR.
The EMR HbA1c levels of the respondents ranged from 5.0 to 14.6 with a mean of 7.87 ± 1.69.
EMR HbA1c was missing for only seven patients (3.30%). Wherever possible, missing survey
data was supplemented with EMR data extracted from the patient records and was used for
further analysis. Based on the HBA1c levels, three groups were created - ‘Well controlled’
(HbA1c ≤ 7), ‘Moderately Uncontrolled’ (7 < HbA1c ≥ 9), and ‘Severely Uncontrolled’ (HbA1c
> 9).
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Table 4.2: Baseline Characteristics of Patient Sample (Stratified by Glycemic Control)
Characteristics
Total Sample HbA1c ≤ 7 7 < HbA1c ≤ 9 HbA1c > 9 P Value
(N= 210)
(N=67)
(N=82)
(N=37)
N (%)
N (%)
N (%)
N (%)
63.5 (11.8)
66.3 (10.2)
62.7 (12.7)
60.6 (11.9)
Mean age (SD)
< 0.01*
Age Group
46 – 55 Years
41 (19.5)
5 (12.2)
25 (61.0)
11 (26.8)
56 – 65 Years
64 (30.50)
21 (35.6)
23 (39.0)
15 (25.4)
> 65 Years
88 (25.20)
41 (47.7)
34 (39.5)
11 (12.8)
0.24
Gender
Male
108 (51.40)
33 (44.0)
50 (56.8)
22 (55.0)
Female
102 (48.60)
42 (56.0)
38 (43.2)
18 (45.0)
0.17
Ethnicity
Caucasian
197 (93.80)
70 (94.6)
83 (95.4)
38 (95.0)
African-American
5 (2.4)
4 (5.4)
0 (0.0)
5 (2.5)
Asian
2 (1.0)
0 (0.0)
2 (2.3)
2 (1.0)
Other
3 (1.4)
0 (0.0)
2 (2.3)
3 (1.5)
0.40
Education
High school/
97 (46.20)
34 (36.5)
38 (40.9)
21 (22.6)
vocational
35 (16.70)
13 (37.1)
14 (40.0)
8 (22.9)
Some College
39 (18.60)
16 (44.4)
14 (38.9)
6 (16.7)
College
38 (18.10)
12 (31.6)
22 (57.9)
4 (10.5)
Graduate
0.91
Marital Status
Currently Married
126 (60.00)
46 (37.4)
52 (42.3)
25 (20.3)
Divorced/ Separated
32 (15.20)
11 (35.5)
16 (51.6)
4 (12.9)
Widowed
31 (14.80)
11 (37.9)
13 (44.8)
5 (17.2)
Never Married
20 (9.50)
7 (36.8)
7 (36.8)
5 (26.3)
0.81
Yearly Income
≤ $25,000
58 (27.60)
19 (33.9)
22 (39.3)
15 (26.8)
$25,001 - $50,000
54 (25.70)
17 (32.7)
26 (50.0)
9 (17.3)
$50,001 - $75,000
33 (15.70)
12 (38.7)
13 (41.9)
6 (19.4)
$75,001 - $100,000
21 (10.00)
8 (40.0)
10 (50.0)
2 (10.0)
≥ 100,001
23 (11.00)
6 (26.1)
11 (47.8)
6 (26.1)
< 0.05*
Insurance
Medicare
107 (51.00)
51 (49.0)
38 (36.5)
15 (14.4)
Medicaid
9 (4.30)
3 (33.3)
4 (44.4)
2 (22.2)
Private
66 (31.40)
16 (24.6)
34 (52.3)
15 (23.1)
Self-Paid
6 (2.90)
3 (50)
2 (33.3)
1 (16.7)
Other
15 (7.10)
1 (7.7)
8 (61.5)
4 (30.8)
0.58
Employment
Full – Time
53 (25.20)
15 (28.3)
27 (50.9)
11 (20.8)
Part – Time
15 (7.10)
6 (42.9)
4 (28.6)
4 (28.6)
Retired
114 (54.30)
45 (41.3)
46 (42.2)
18 (16.5)
Unemployed
24 (11.40)
8 (34.8)
9 (39.1)
6 (26.1)
0.50
Smoking
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Current Smoker
Former Smoker
Non-Smoker
Referral to an
Endocrinologist
Comorbidities
Cardiovascular Disease
Hypertension
Renal Failure
Peripheral Neuropathy
Retinopathy
Depression
Anxiety
Obesity

18 (8.60)
72 (34.30)
116 (55.20)
56 (26.70)

6 (33.3)
27 (39.7)
40 (35.4)
14 (25.9)

6 (33.3)
31 (45.6)
50 (44.2)
24 (44.4)

6 (33.3)
10 (14.7)
23 (20.4)
16 (29.6)

< 0.05*

57 (27.10)
156 (74.30)
14 (6.70)
39 (18.60)
26 (12.40)
50 (23.80)
43 (20.50)
62 (29.50)

20 (37.0)
59 (39.3)
3 (23.1)
11 (29.7)
6 (26.1)
15 (30.6)
18 (42.9)
22 (36.7)

19 (35.2)
65 (43.3)
5 (38.5)
17 (45.9)
12 (52.2)
22 (44.9)
18 (42.9)
28 (46.7)

15 (27.8)
26 (17.3)
5 (38.5)
9 (24.3)
5 (21.7)
12 (24.5)
6 (14.3)
10 (16.7)

0.17
0.29
0.19
0.55
0.51
0.48
0.53
0.73

Chi square test were used with significance level set at p < 0.05.
*Significant associations
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Validation of survey responses using EMR
This study utilized survey methods to collect information about patient demographic
characteristics, clinical outcomes such as most recent HbA1c level and patient beliefs about selfcare activities. Additionally, information regarding their demographic characteristics and most
recent HbA1c level was also collected from their EMR. For variables collected through both
sources, the correlation between the survey responses and recorded EMR responses were
examined to validate the survey responses. It was found that age measured through EMR was
strongly correlated with age captured through survey response (Pearson’s correlation r = 0.940, p
< 0.0001). Similarly, the HbA1c recorded in the EMR significantly correlated with the selfreported HbA1c level, though the correlation was moderate (Pearson’s correlation r = 0.629, p <
0.001).
Patients’ Self-Care Behaviors
In addition to the demographic variables, the patient survey collected information about
the patient’s self-care behaviors such as diabetes self-management, knowledge of diabetes,
attitudes and beliefs regarding their disease, their readiness to change their health related
behaviors, and their preference for oral hypoglycemic agents and/ or insulin. These self-care
behaviors were measured using standardized questionnaires:
a. Diabetes Self-Management Questionnaire (DSMQ)
The total DSMQ scores ranged from 2.08 to 9.17 with a mean score of 6.75 ± 1.31.
Higher scores indicate more desirable self-management behavior. DSMQ scores were divided
into 4 quartiles: 0.00-2.50, 2.51-5.00, 5.01-7.50 and 7.50-10.00. As only one respondent scored
below 2.51, we merged the lower two categories into 0.00-5.00 for the purpose of further
66

analyses. The final categories were ‘Low self-management’ (DSMQ score of 5 or below),
‘Average self-management’ (DSMQ score between 5.01 and 7.50), and ‘High self-management
(DSMQ score above 7.50). A total of 17 respondents (8.4%) reported low self-management, 124
respondents (61.1%) reported average self-management and 62 respondents (30.5%) reported
high self-management. A higher proportion of patients with HbA1c < 7 had higher DSMQ scores
as compared to uncontrolled HbA1c groups (refer Table 4.3).
b. Diabetes subscale of Diabetes, Hypertension and Dyslipidemia (DHL) Questionnaire
The possible scores on the DHL instrument range from 0-10. The DHL scores were
categorized as ‘Low knowledge’ for scores ≤ 5 and ‘High knowledge’ for scores > 5. The
respondents’ DHL scores ranged from 0 to 8 with a mean DHL score of 4.82 ± 1.31. A total of
159 respondents (75.70%) were found to have low knowledge of their diabetes while 51
respondents (24.30%) were found to have high knowledge of their diabetes (Table 4.4).
c. The Revised Illness Perception Questionnaire (IPQ - R)
The Revised Illness Perception Questionnaire (IPQ - R) was employed to understand the
patients’ attitudes and beliefs about their disease. Some items are negatively worded to minimize
respondent bias. In the IPQ-R questionnaire (refer Table 4.5), items 1 through 6 capture the
respondents’ beliefs about the timeline (acute/ chronic) of their disease. A majority of
respondents perceived that their illness is chronic in nature and will last a long time. A majority
of the patients perceived their illness to have serious consequences (items 7 through 12).
However, the financial consequences were perceived to be serious by only 42.8% of the
respondents. A small proportion of respondents (29.60%) agreed that their illness caused
difficulties for those who are close to the patients (caregivers). Items 13 through 17 measured the
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respondents’ perceptions about their personal control. A majority of respondents believed that
they had the power to control their illness. Items 18 through 20 measure the respondents’
perceptions about their treatment control. A majority of respondents perceived that their
treatment can control their illness. Items 21 through 25 measures perceived coherence of disease.
A majority of respondents did not find their disease puzzling, and had a clear picture or
understanding of their illness. Items 26 through 28 measured the respondents’ perceptions about
the cyclic nature of the symptoms of their illness. Relatively few respondents agreed that the
symptoms of their illness changes from day to day or they come and go in cycles. A greater
proportion of respondents perceived the symptoms of their disease to be consistent over time.
Items 29 through 34 measured the emotional representations of respondents about their disease.
A majority of respondents disagreed that their illness makes them depressed or upset, worries
them, makes them angry, anxious or afraid.
d. Readiness to Change
The respondents were enquired about their readiness to change their healthcare behavior
in accordance with the Trans-theoretical model of change. It was found that of the patients for
whom HbA1c level was available through the EMR (N = 193), 21 patients (10.9%) were in the
pre-contemplation or contemplation phase, 41 patients (21.2%) were in the preparation phase, 93
patients (48.2%) were in the action phase and 38 patients (19.7%) were in the maintenance
phase. A higher proportion of patients who had HbA1c levels < 7, were in Action and
Maintenance phase, as compared to patients in other groups (Table 4.6).
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e. Willingness to take Medications
A total of 63 patients (30%) showed low willingness for taking insulin (score: 0-5) while
122 patients (58.1%) showed high willingness to take insulin (score: 6-10) (Table 4.7). The mean
willingness to take insulin score was 6.94 ± 3.58. Responses were missing for 25 patients
(11.9%), who chose not to answer that question. Only 18 patients (8.6%) had a low willingness
for taking oral hypoglycemic agents (score: 0-5), with 174 patients (82.9%) in favor of taking
them (score: 6-10). The mean willingness to take hypoglycemic agents score was 9.06 ± 2.24. 18
respondents (8.6%) did not respond to this question. The willingness to take either medication
was not correlated with the patients’ readiness to change.
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Table 4.3: Diabetes Self-Management Questionnaire (DSMQ)
Category
Total Sample
HbA1c ≤ 7
7 < HbA1c ≤ 9
N (%)
0.00 to 2.50
1 (0.5)
0 (0)
0 (0)
2.51 to 5.00
16 (7.9)
1 (1.3)
8 (9.1)
5.01 to 7.50
124 (61.1)
47 (62.7)
56 (63.6)
7.51 to 10.00
62 (30.5)
27 (36.0)
24 (27.3)
Chi square test was performed with significance level set at p < 0.05.
Higher DSMQ score suggests better self-management of diabetes.
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HbA1c > 9

P value

1 (2.5)
7 (17.5)
21 (52.5)
11 (27.5)

< 0.05

Table 4.4: Diabetes, Hypertension, and Hyperlipidemia (DHL) Questionnaire
Category
Total Sample HbA1c ≤ 7
7 < HbA1c ≤ HbA1c > 9
P value
N (%)
9
Low (0-5)
159 (75.7)
59 (78.7)
71 (80.7)
26 (65.0)
0.13
High (6-10)
51 (24.3)
16 (21.3)
17 (19.3)
14 (35.0)
Chi square test was performed with significance level set at p < 0.05.
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Table 4.5: Revised Illness Perception Questionnaire (IPQ-R)
Sr.
Item
Proportion of respondents (%)
no.
Strongly Agree
Strongly
Disagree
A. Timeline of disease (acute/ chronic)
1
My illness will last a short time
10.0
1.0 3.8 9.5 73.3
2
My illness is likely to be permanent rather than
62.4
10.0 9.0 3.3 11.9
temporary
3
My illness will last a long time
62.9
9.5 11.4 3.3 8.6
4
This illness will pass quickly
9.0
0.0 3.8 7.1 76.2
5
I expect to have this illness for the rest of my life
61.4
9.5 9.5 2.4 12.9
6
My illness will improve in time
11.4
15.7 21.0 14.8 32.4
B. Consequences
7
My illness is a serious condition
63.8
15.7 5.7 2.9 9.5
8
My illness has major consequences on my life
56.2
14.8 11.0 6.7 9.5
9
My illness does not have much effect on my life
9.5
6.2 18.1 13.3 51.0
10
My illness strongly affects the way other see me
8.6
4.8 21.4 13.3 49.0
11
My illness has serious financial consequences
25.2
17.6 27.1 12.4 14.3
12
My illness causes difficulties for those who are
14.8
14.8 21.9 12.4 31.4
close to me
C. Personal Control
13
There is a lot I can do to control my illness
61.4
22.4 8.6 1.4 3.8
14
What I do can determine whether my illness gets
59.0
19.0 11.4 1.4 5.2
better or worse
15
The course of my illness depends on me
54.8
22.9 9.0 5.7 5.2
16
Nothing I do will affect my illness
8.1
3.8 5.7 10.0 68.6
17
I have the power to influence my illness
54.3
21.9 12.4 3.8 5.2
D. Treatment Control
18
The negative effects of my illness can be
34.8
28.6 22.9 4.8 5.7
prevented by my treatment
19
Treatment can control my illness
49.0
28.1 11.9 2.4 6.2
20
There is nothing that can help my illness
6.2
2.4 8.6 11.4 68.1
E. Perceived Coherence
21
The symptoms of my illness are puzzling to me
7.6
11.9 21.0 18.6 38.1
22
My illness has no meaning to me
7.1
2.9 8.6 8.6 69.5
23
I don’t understand my illness
5.7
7.6 19.0 15.7 48.6
24
My illness doesn’t make any sense to me
6.7
8.1 14.8 17.6 49.0
25
I have a clear picture or understanding of my
36.7
20.5 23.3 10.0 5.7
illness
F. Timeline (Cyclic Nature of Disease)
26
The symptoms of my illness change from day to
16.2
13.3 25.7 16.2 25.2
day
27
My symptoms come and go in cycles
13.8
10.5 20.5 19.5 32.4
28
I go through cycles in which my illness gets
17.1
12.4 26.7 16.7 23.3
better and worse
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29
30
31
32
33
34

G. Emotional Representation of Disease
I get depressed when I think about my illness
16.2
13.8
When I think about my illness I get upset
13.8
11.9
My illness makes me feel angry
14.8
11.0
My illness does not worry me
8.1
10.5
My illness makes me feel anxious
11.4
11.0
My illness makes me feel afraid
11.4
13.8
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18.1
21.0
17.6
17.6
26.7
19.5

13.3
9.0
13.3
19.5
10.5
20.0

36.2
40.5
40.0
40.5
27.1
32.4

Table 4.6: Readiness to Change
Category
Total Sample
N = 193 (%)
Pre21 (10.9)
contemplation &
contemplation
Preparation
41 (21.2)
Action
93 (48.2)
Maintenance
38 (19.7)

HbA1c ≤ 7

7 < HbA1c ≤ 9

HbA1c > 9

P value

6 (8.5)

10 (11.8)

5 (13.5)

< 0.61

11 (15.5)
38 (53.5)
16 (22.5)

23 (27.1)
37 (43.5)
15 (17.6)

7 (18.9)
18 (48.6)
7 (18.9)

Chi square test was performed with significance level set at p < 0.05.
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Table 4.7: Willingness to Take Medications
Category
Total Sample HbA1c ≤ 7
N (%)
OHAs
0-5
18 (8.6)
8 (11.0)
6-10
174 (82.9)
65 (89.0)
Insulin
0-5
63 (30.0)
30 (47.6)
6-10
122 (70.0)
33 (52.4)

7 < HbA1c ≤
9

HbA1c > 9

0.59
7 (9.5)
67 (90.5)

2 (5.1)
37 (94.9)
< 0.01

23 (28.4)
58 (71.6)

7 (19.4)
29 (80.6)

Chi square tests were performed and significance level was set at p < 0.05.
Willingness to take insulin was higher in severely uncontrolled patients compared to other groups.
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P value

Univariate Relationships
Univariate relationships between HbA1c control and respondent characteristics and selfcare behaviors were examined to identify variables that were significantly associated with
HbA1c control in this population. Other dependent variables in this study were readiness to
change and level of self-management as measured by the DSMQ questionnaire. Univariate
associations between these variables, and respondent characteristics and self-care behaviors were
also examined. Chi square statistic was used to examine these associations. Fisher’s exact test
was used by SPSS instead of a chi square test, if any cell size was less than or equal to 5.
Relationships between HbA1c control and Patient Characteristics:
Age was significantly associated with HbA1c control, indicating that the HbA1c control
varied significantly across age groups (chi square = 15.73, p < 0.01) (Table 4.8). Other variables
that were significantly associated with HbA1c control were referral to an endocrinologist (chi
square = 6.17, p < 0.05), diabetes self-management measured through DSMQ (chi square =
12.01, p < 0.05), willingness to take insulin (chi square = 9.8, p < 0.01), and insurance status (chi
square = 12.03, p < 0.05). HbA1c control was not associated with years since diagnosis,
willingness to take OHAs, readiness to change, gender, education level, marital status, annual
income, employment status, smoking status, knowledge of diabetes measured by DHL
questionnaire.
Relationships between DSMQ Scores and Patient Characteristics:
The Diabetes Self-Management Questionnaire (DSMQ) measured the level of selfmanagement in the study population. The DSMQ scores were significantly associated with the
HbA1c control as measured from EMR (chi square = 12.01, p < 0.05) and with readiness to
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change (chi square = 33.04, p < 0.001) (Table 4.9). The association between DSMQ score and
variables such as age, willingness to take insulin or OHAs, response status, the patient’s
knowledge of diabetes as measured by the DHL questionnaire, years since diagnosis of diabetes,
referral to an endocrinologist, smoking status, employment status, insurance coverage, marital
status, annual income, and level of education.
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Table 4.8: Relationship between HbA1c and Patient Characteristics
Characteristics
χ2
D.F.
Age
Diabetes Self-Management (DSMQ)
Willingness to take Insulin
Insurance Status
Referral to an Endocrinologist

17.19
12.01
9.80
12.03
6.17

Chi square tests were performed and significance level was set at p < 0.05.
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4
4
2
4
2

p – value
< 0.01
< 0.05
< 0.01
< 0.05
< 0.05

Table 4.9: Relationships between Self-Management (DSMQ) and Patient Characteristics
Characteristics
χ2
D.F.
p – value
HbA1c Control
Readiness to Change

12.01
33.04

Chi square tests were performed and significance level was set at p < 0.05.
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4
6

< 0.05
< 0.001

Determinants of Glycemic Control
An objective of this study was to identify the factors associated with glycemic control in
the study population. Glycemic control measured through most recent HbA1c value in EMR is
the primary outcome variable in this study. It is operationalized as well-controlled (HbA1c ≤ 7),
moderately uncontrolled (7 < HbA1c > 9), and severely uncontrolled (HbA1c ≥ 9). As the
response variable (HbA1c control) has more than two categories, multinomial logistic regression
was utilized. A backward stepwise approach was used to specify the model. The first model
tested for main effects and all the independent (predictor) variables were entered in the model.
The backward stepwise approach utilized 0.1 as the probability for a variable to exit the model.
This procedure provided a model with age, DSMQ score, ‘willingness to take insulin’, and level
of education. In the second model, the variables observed in the first model were forced entered
and the interactions of age with other variables were entered in a stepwise manner. None of the
interaction terms were significant and the resulting model was the same as model 1. The results
of the multinomial regression model are presented in the Table 4.10 below:
𝑙𝑜𝑔𝑖𝑡 [𝐸(𝑌)|𝑋𝑖 ]
= 𝛽0 + 𝛽1𝑠𝑒𝑙𝑓 − 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 (𝐷𝑆𝑀𝑄) + 𝛽2 𝑎𝑔𝑒 𝑙𝑒𝑠𝑠 𝑡ℎ𝑎𝑛 50 + 𝛽3 𝑎𝑔𝑒 50
− 65 + 𝛽4 𝑙𝑜𝑤 𝑤𝑖𝑙𝑙𝑖𝑛𝑔𝑛𝑒𝑠𝑠 𝑡𝑜 𝑡𝑎𝑘𝑒 𝑖𝑛𝑠𝑢𝑙𝑖𝑛
+ 𝛽5 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 ℎ𝑖𝑔ℎ 𝑠𝑐ℎ𝑜𝑜𝑙 𝑜𝑟 𝑙𝑒𝑠𝑠
+ 𝛽6 𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑙𝑙𝑒𝑔𝑒 𝑜𝑟 𝑠𝑜𝑚𝑒 𝑐𝑜𝑙𝑙𝑒𝑔𝑒
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Table 4.10: Parameter Estimates from Multinomial Logistic Regression for HbA1c control
95% CI for Odds Ratio
Lower
Odds
Upper
Moderately Uncontrolled Vs. Well-controlled
DSMQ score
0.47
0.67
0.95
Age < 50 years
1.45
4.90
16.49
Age 50 – 65
0.62
1.65
4.42
Age > 65
Ref.
Low willingness to take Insulin
0.11
0.30
0.80
High willingness to take Insulin
Ref.
Education high school or less
0.15
052
1.77
Education college or some college
0.07
0.25
0.86
Education graduate
Ref.
Severely Controlled Vs. Well-controlled
DSMQ score
0.38
0.57
0.76
Age < 50 years
1.42
6.37
28.51
Age 50 – 65
0.95
3.20
10.85
Age > 65
Ref.
Low willingness to take Insulin
0.03
0.14
0.56
High willingness to take Insulin
Ref.
Education high school or less
0.41
2.68
17.61
Education college or some college
0.16
1.03
6.85
Education graduate
Ref.
Note: R2 = 0.27 (Cox and Snell) and 0.31 (Nagelkerke); Model χ 2 (16) = 41.23, p < 0.01
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Patient’s level of self-management as measured by DSMQ scores was significantly
associated with HbA1c control. A unit increase in DSMQ score was associated with 49%
decreased odds of being moderately uncontrolled, and 75% decreased odds of being severely
uncontrolled than well-controlled. Age was significantly associated with HbA1c control.
Specifically, patients aged younger than 50 years were 4.9 times more likely to be moderately
uncontrolled (OR=4.9, 95%CI=1.45, 16.49), and 6.4 times more likely to be severely
uncontrolled (OR=6.37, 95%CI=1.42, 28.51) than well-controlled as compared to patients over
65 years of age. Patients who showed low willingness to take insulin were 7.15 times less likely
to be moderately uncontrolled than well-controlled as compared to patients who showed high
willingness to take insulin (OR=0.30, 95%CI=0.11-0.80), and 3.3 times less likely to be severely
uncontrolled than well-controlled (OR=0.14, 95%CI=0.03-0.56). Interestingly, patients with
college education were 4 times less likely to be moderately uncontrolled than well-controlled as
compared to patients with graduate level education (OR=0.25, 95%CI=0.07-0.86). The
associations of other variables in the regression model with HbA1c control remained nonsignificant.
Objective 2: To assess patients’ readiness to change their diabetes self-management behavior
Relationships between Readiness-to-Change and Patient Characteristics
The variable ‘readiness to change’ measured the patients’ willingness to change their
diabetes related behaviors. Patients who were referred to an endocrinologist by their primary care
physicians differed significantly in their readiness to change their diabetes related behaviors (chi
square = 11.86, p < 0.01) (Table 4.11). Additionally, self-management level as measured by
DSMQ was significantly associated with readiness to change (chi square = 33.04, p < 0.001).
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Demographic variables such as age, gender, ethnicity, education, marital status, annual income,
insurance status, employment status, and knowledge as measured by DHL, were not significantly
associated with readiness to change.
Physician Survey
Objective 3: To identify physician perceived barriers to diabetes self-management.
The physician survey collected information about the physicians’ beliefs about their
clinical practice and their patients’ self-management behaviors. The target sample was composed
of physicians working in the PPCP group (n = 39). The survey was administered during the
PPCP group’s monthly meeting held in June 2014. Out of a total sample of 39, 24 responses
were obtained which included 21 physicians and 3 medical staff members (1 physician assistant,
1 transition-of-care liaison and 1 nurse practitioner). The physicians were all males and the
medical staff members were all females. The analyses only included responses from the 21
physicians (response rate = 53.8%) as we were interested in assessing the barriers to diabetes
self-management as perceived by providers, who were directly involved in treating this patient
population.
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Table 4.11: Relationships between Readiness to Change and Patient Characteristics
Characteristics
χ2
D.F.
p – value
Level of Self-management (DSMQ)
Referral to an Endocrinologist

33.04
11.11

Chi square tests were performed and significance level was set at p < 0.05.
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6
3

< 0.001
< 0.01

Demographic and Practice Characteristics:
The survey respondents included 21 physicians and 3 medical staff members. The
analyses were conducted on responses from the 21 physicians only. 71.42% respondents were
older than 50 years of age (mean = 53.81 ± 8.93). Over 50% of the respondents (13 out of 24)
had more than 25 years of clinical experience (mean = 23.90, SD ± 9.19). 50% of the
respondents had their practice in an urban setting. The respondents examined from 5 to 60
patients with T2DM per week (mean = 20.95 ± 12.06) and a majority of physicians (76.20%)
spent less than 20 minutes on a face-to-face visit (refer Table 4.12).
The physician questionnaire also enquired about other attributes of the physicians’
practices such as the number of face-to-face interactions they have with their patients with
T2DM in a 3-month period and the number of follow-ups they conduct between two face-to-face
interactions. A majority of physicians had 1 – 2 face-to-face interactions with their patients with
T2DM every 3 months. Interestingly, around 20% of physicians interacted face-to-face with their
T2DM patients more than 5 times in a 3-month interval. Follow-up was conducted by over 80%
of the respondents, with 14.28% respondents following up with their patients at least 3 times
between two face-to-face visits. Follow-up care was offered by all of the participating
physicians’ practices. Therefore, the physician survey also enquired about the reasons for not
receiving follow-up care in those patients who did not receive/ seek follow-up. Over half of the
respondents (57.10%) agreed that follow up care was not sought by some patients as they
believed they have adequate knowledge of the disease and thus, do not require follow-up. The
respondents did not believe that their lack of contact with patients was a reason for no follow up.
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Table 4.12: Characteristics of Physician Practice
Continuous Variables
Characteristics
Age
Years in Practice
Number of Patients Examined Per Week
Categorical Variables
Characteristics
Age Category
≤ 50 years
> 50 years
Years of Experience
≤ 25 years
> 25 years
Location of Practice
Urban
Rural
Average time per patient per visit
15 min
20 min
25 min
30 min
Number of patients per week
≤ 10
11 – 20
> 20
Number of interactions in a 3-month interval
1
2
Number of follow up visits in a 3-month
interval
2
3

Mean (SD)
53 ± 8.93
23.9 ± 9.19
20.95 ± 12.06
Total Sample (21)
N (%)
6 (28.58)
15 (71.42)
8 (38.1)
13 (61.9)
11 (52.4)
10 (47.6)
9 (42.9)
7 (33.3)
2(9.5)
3 (14.3)
3 (14.3)
10 (47.6)
7 (33.3)
14 (66.7)
7 (33.3)
18 (85.7)
3 (14.3)
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Around 19% of the respondents believed lack of time to interact with patients to be a reason for
no follow up in their patients. 23.8% of the respondents believed that patients cannot afford
follow-up care. Lack of internal support (staff, funding, materials and equipment) was not
considered as a reason for ‘no follow-up’ by over 80% of the respondents. Other reasons
provided by physicians include non-compliance, patient indifference and patients’ lack of
concern for their own health and their inability to keep up with appointments.
The respondents were requested to report the reasons for referring their patients with
T2DM to an endocrinologist. 19 respondents considered the uncontrolled nature of their patients’
disease as a reason for the referral. Six respondents cited the need for insulin therapy or insulin
pump as a reason for referral to an endocrinologist. Non-compliance and poor adherence were
the other reasons commonly cited by the respondents as reasons for referral to the
endocrinologist. Presence of co-morbidities (other endocrine disorders such as T1DM), extreme
resistance to insulin, necessity of multiple adjustments to therapy, and patient request were other
reasons noted by the respondents for the referral.
Beliefs about Patient Self-Care:
An important objective of the physician questionnaire was to identify the physicians’
perceptions about the importance and level of difficulty of their patients’ self-care activities.
These activities include regular moderate exercise, following a recommended diet, regular blood
glucose testing, proper insulin administration and adherence to oral medication. In doing so, a 5point Likert scale was utilized where 1 = ‘not important at all/ not difficult at all’ and 5 =
‘extremely important/ extremely difficult’. Additionally, physicians were asked the proportion of
their patients who were adherent to these self-care activities. Again, a 5-point Likert scale (1 =
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‘less than 30%’, 2 = ‘30-50%’, 3 = ‘50-70%’, 4 = ’70-90%’ and 5 = ‘more than 90 %’) was
utilized to measure the proportion of adherent patients (as perceived by their physicians).
Table 4.13 summarizes the survey responses about the physicians’ beliefs about their
patients’ self-care activities. Self-care activities included Regular moderate exercise, following a
recommended diet, regular blood glucose testing, proper insulin administration (in patients who
need insulin therapy), and adherence to oral medications. It was observed that a majority of
physicians (around 95%) considered these self-care activities extremely important. A higher
degree of variation was observed in the physicians’ perception of the level of difficulty the
patients face in performing these activities. However, over half the respondents considered
regular moderate exercise (85.71%), following a recommended diet (80.95%) and proper insulin
administration (61.90%) as at least ‘difficult’. Interestingly over half the respondents perceived
adherence to medication and regular blood glucose testing as ‘slightly difficult’ or ‘not difficult
at all’ (52%, 38%). 76.19% of the respondents believed that less than 50% of their patients are
adherent to regular moderate exercise or following a recommended diet. However, at least 60%
of the respondents believed that over half of their patients were adherent to regular blood glucose
testing, proper insulin administration and took their oral medications as prescribed.
Beliefs about Physician Practice:
The study sought to identify the physicians’ beliefs about aspects of their practices such
as the physician-patient communication, patient health literacy and patient follow-up.
Specifically, the study assessed how important the physicians believed these aspects of their
practice to be in managing their patients with T2DM, how they rated their performance on these
aspects, and how satisfied they were with their performance. A 5-point Likert scale was utilized
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to collect this information. It was found that all the aforementioned aspects were considered
extremely important or very important by a majority of respondents (95.23% - 100.00%).
Overall, physicians rated their performance on these measures positively. A majority of
respondents (over 90%) showed satisfaction with their performance on these measures (Table
4.14).
A sizable proportion of the respondents (66.67 %) considered themselves responsible to
some extent for their patients’ failure to achieve their self-management goals. However, around
30% of the respondents believed they are not responsible for their patients’ failure to achieve
their self-management goals. Interestingly, there was a strong association between physician
perceived responsibility of patient’s failure to achieve self-management goals and self-rated
performance on patient follow-up (chi square = 27.34, p < 0.001), self-rated satisfaction with
patient follow up (chi square = 21.83, p < 0.01), and self-rated satisfaction with patient health
literacy (chi square = 17.68, p < 0.01).
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Table 4.13: Self-care activities
Regular moderate
exercise
N (%)

Following a
recommended diet
N (%)

Adherence to oral
medication
N (%)
0 (0)
0 (0)
0 (0)
1 (4.8)
20 (95.2)
21 (100)
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Not important at all
Slightly Important
Important
Very important
Extremely Important
Total

0 (0)
0 (0)
0 (0)
1 (4.8)
20 (95.2)
21 (100)

0 (0)
0 (0)
0 (0)
2 (9.5)
23 (90.5)
21 (100)

Not difficult at all
Slightly difficult
Difficult
Very difficult
Extremely difficult
Total

0 (0)
3 (14.3)
9 (42.9)
3 (14.3)
6 (28.6)
21 (100)

2 (9.5)
2 (9.5)
6 (28.6 )
5 (23.8)
6 (28.6)
21 (100)

Less than 30%
30-50%
50-70%
70-90%
More than 90%
Total

9 (42.9)
7 (33.3)
4 (19.0)
1 (4.8)
0 (0)
21 (100)

7 (33.3)
9 (42.9)
3 (14.3)
2 (9.5)
0 (0)
21 (100)

Regular blood
Proper insulin
glucose testing
administration
N (%)
N (%)
Importance
0 (0)
0 (0)
0 (0)
0 (0)
7 (33.3)
0 (0)
4 (19.0)
1 (4.8)
10 (47.6)
20 (95.2)
21 (100)
21 (100)
Difficulty
6 (28.6)
2 (9.5)
5 (23.8)
6 (28.6)
6 (28.6)
10 (47.6)
4 (19.0)
2 (9.5)
0 (0)
1 (4.8)
21 (100)
21 (100)
Proportion of adherent patients
3 (14.3)
1 (4.8)
4 (19.0)
1 (4.8)
9 (42.9)
9 (42.9)
5 (23.8)
9 (42.9)
0 (0)
1 (4.8)
21 (100)
21 (100)

5 (23.8)
11 (52.4)
4 (19)
1 (4.8)
0 (0)
21 (100)
1 (4.8)
1 (4.8)
9 (42.9)
7 (33.3)
3 (14.3)
21 (100)

Table 4.14: Physician Beliefs regarding their Practices
Physician-Patient
Patient Health
Communication
Literacy
N (%)
N (%)
Importance
Not at all important
0 (0)
0 (0)
Slightly important
0 (0)
0 (0)
Important
0 (0)
1 (4.8)
Very important
0 (0)
7 (33.3)
Extremely important
21 (100)
13 (61.9)
Total
21 (100)
21 (100)
Performance
Very poor
0 (0)
0 (0)
Poor
0 (0)
2 (9.5)
Average
2 (9.5)
10 (47.6)
Good
11 (52.4)
6 (28.6)
Very good
8 (38.1)
2 (9.5)
Total
21 (100)
20 (95.2)
Satisfaction
Not satisfied at all
0 (0)
0 (0)
Slightly satisfied
1 (4.8)
2 (9.5)
Satisfied
4 (19.0)
10 (47.6)
Very satisfied
10 (47.6)
7 (33.3)
Extremely satisfied
6 (28.6)
2 (9.5)
Total
21 (100)
21 (100)
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Patient Follow-Up
N (%)
0 (0)
0 (0)
0 (0)
3 (14.3)
18 (85.7)
21 (100)
0 (0)
1 (4.8)
5 (23.8)
11 (52.4)
4 (19.0)
21 (100)
0 (0)
1 (4.8)
6 (28.6)
9 (42.9)
5 (23.8)
21 (100)

Objective 4: To explore physicians’ challenges to overcome the barriers to self-management.
In order to identify the challenges physicians faced in managing their T2DM patients, the
questionnaire further probed the major reasons of clinical inertia in their practices. ‘Clinical
Inertia’ or ‘Therapeutic Inertia’ is defined as the lack of treatment intensification in patients who
are not on “evidence-based goals” for care. The information was collected using open-ended
questions and the analysis of this qualitative data was conducted to identify the common themes
from the physicians’ and their medical staff members’ responses. Ryan and Bernard suggest
various techniques to identify themes in qualitative research.71 Based on the nature of the
responses collected in this survey, coding of responses into themes was performed using simple
techniques such as:
1. Repetitions: The words or phrases that were repeated in different responses were
identified. Same thoughts expressed across responses irrespective of different wordings
were also identified.
2. Cutting and Sorting: The identified content within each theme was cut into individual ideas
and sorted into subthemes.
3. Similarities and Differences: The subthemes created were based on the similarities or
difference between the ideas expressed.
There were several themes that emerged from the physicians’ responses about the barriers that
led to clinical inertia in their practice and these are summarized below.71, 72
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a. Costs
The most common theme resonating in the responses was the costs associated with managing
T2DM. Cost of medications was the most cited barrier that led to clinical inertia. Other costs
such as those incurred for office visits (due to copay issues), costs for purchasing insulin
monitoring equipment, and additional costs associated with healthy food choices (lean proteins
and vegetables) were also mentioned by the respondents as barriers to intensification of therapy
in their T2DM patients.
b. Patient Motivation and Interest
A few respondents noted that lack of patient interest and their unwillingness to change their
health-related behaviors prevented the practitioners from intensifying treatment and improving
the health outcomes of their patients. Furthermore, as mentioned by one of the respondents, the
lack of motivation from the patient made the practitioner pessimistic about being able to manage
this type of patients. It was observed by another respondent that patients find it difficult ‘to curb
their appetite for good tasting bad foods and prefer to watch TV than exercise’. Patient’s lack of
confidence in guidelines, which are often inconsistent among various organizations that publish
them, was cited as another reason for patient’s reluctance to change.
c. Knowledge
A respondent noted that there was lack of in-office diabetes education for the patients in their
practice while another respondent found it difficult to get the patients to attend diabetes
education outside of office visits. In general, the respondents believed that their patients did not
feel they were ill or were in denial about their problems, some being unaware of secondary
problems such as blindness and renal failure associated with unmanaged T2DM. Patients’ fear of
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injectable medications and hypoglycemia also prevented their physicians from intensifying
treatment.
d. Non-compliance with Diet and Medications
Patient’s non-compliance with diet, exercise and medications was cited as a barrier to treatment
intensification by many respondents (47.62%). A respondent also mentioned that the patients do
not keep up with scheduled visits and follow ups.
e. Polypharmacy
The respondents noted that their patients were already on multiple medications as part of their
therapy and thus, it was difficult for the physicians to add more medications to their treatment
regimen. Comorbidities often led to increased number of prescribed medications and could cause
drug-drug interactions. Some patients were also reported to develop resistance to oral
medications as well as insulin, making treatment difficult. A respondent mentioned that ‘newer
medications and their changing roles caused the patients and providers to stick to old patterns’.
All these factors associated with polypharmacy also lead to clinical inertia according to the
survey respondents.
f. Lack of Time
The respondents acknowledged that they do not have enough time to focus on their patients’
diabetes related complications as the patients often have other chronic illnesses that require their
attention during the office visits. Consequentially, the physicians have to let the patients work on
their diet regimen and exercise, without being able to provide much care in that regard. They also
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believed that the office visits were too few to be able to allocate enough time to address their
patients T2DM related complications.
g. Social support
Family dynamics and lack of support from home (family members) to embrace a healthy lifestyle
that includes proper diet regimen and regular exercise, was reported to be a barrier to treatment
intensification by the physicians.
h. Miscellaneous
Apart from the aforementioned themes, barriers such as medication side-effects, reimbursement
issues, and patients’ frustration due to not reaching goals or seeing immediate results were also
reported by the respondents.
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CHAPTER 5: DISCUSSION
The current study provides a comprehensive assessment of barriers and facilitators to
diabetes self-management from the perspectives of patients and their physicians. This chapter
highlights the findings of this study, while comparing and contrasting them to existing literature.
Additionally, this chapter details the conclusion of this study and provides directions for future
research.
This is one of the few studies to have utilized a mixed methods design (survey report to
identify patient characteristics and self-care behaviors, and EMR to obtain clinical data) to
identify patient perceived barriers and facilitators to DSM in a primary care setting.
Supplementing the survey responses with the EMR data provides a unique advantage of
validating self-reported survey responses using the EMR data. The data collected in this study
have better validity than simple surveys since some self-reported variables captured in patient
surveys were validated from the data obtained from patient records in the EMR. Our analysis
showed a strong correlation between the age observed in EMR and the survey reported age. The
HbA1c level of the patients measured through survey report was also strongly correlated with
their recent HbA1c recorded in EMR. This correlation was not as strong as age, as the survey
reported HbA1c levels were approximations based on memory (measured twice a year by the
physician practices), and there was also missing data. Another advantage of linking EMR data to
the survey report was that it enabled us to use the HbA1c variable from EMR as a substitute for
the survey recorded HbA1c to account for the higher proportion of missing values.
The identification of sample and their inclusion for survey administration was carefully
planned to include a heterogeneous group of patients with varying HBA1c values. A stratified
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sampling strategy was employed based on the patients’ HbA1c level as observed from their
EMR. Three equal groups of 700 patients each were randomly selected from patients with
HbA1c ≤ 7, 7.01 < HbA1c < 9, and HbA1c > 9, respectively. Among the respondents, the three
groups were well represented (67, 82, and 37 respondents respectively), due to which all
analyses were conducted across the three groups. The study population was predominantly
Caucasian (94%) but the race distribution in the study sample, however, was consistent with the
overall demographic distribution of Southwestern PA.73 Yet, caution should be exercised while
generalizing the findings of this study in other settings with more diverse patients or comparing
it with results from nationwide studies. Another issue with survey is the response rate. In this
study, the response rate was 10% and thus, a question can arise if those who responded were
different on measured characteristics to those who did not respond. The nonresponse bias was
addressed by comparing early responders to late responders, since literature shows that late
responders had characteristics similar to non-responders.74, 75 There was no significant difference
seen between these two groups, which suggest that non-response bias may not be a threat to our
study findings.
Glycemic control is an important clinical marker in the overall management of T2DM. In
the multivariate regression analysis, it was found that patients with higher self-management
(higher DSMQ score) were more likely to have better glycemic control compared to patients
with poor self-management. This is consistent with previous literature that suggest a strong link
between self-management and better glycemic control, and also with better quality of life and
overall prognosis of disease.8 Another interesting observation was that patients younger than 50
years were more likely to be uncontrolled than patients 65 years and older. This is contrary to
existing knowledge that age is an important risk factor for poor glycemic control.76,77 However, a
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recent US study using National Health and Wellness Survey (NHWS) found that glycemic
control was the poorest in patients aged 18-64 years compared to older age groups.78 The authors
suspected increasing medication adherence with age as a potential reason for better glycemic
control in the older age group as compared to the 18-64 year olds. They also found that
respondents in 18 to 64 year age group had higher lack of awareness of their HbA1c levels.
Thus, both low knowledge and poor adherence could have contributed to these findings. A posthoc analysis of patient DSMQ scores across different age groups in our sample was conducted
which revealed that a much lower proportion of patients aged 50 or younger (14.6%) reported
high DSMQ scores compared to patients in the older age groups (31.3% and 33.2%,
respectively) (p = 0.07) confirming our above inferences. Poor self-management in younger age
group as compared to other age groups can help explain the poor glycemic control in these
patients. Patients who showed low willingness to take insulin were less likely to be uncontrolled.
This finding is consistent with previous literature that suggests that patients, who are
uncontrolled despite using oral hypoglycemic agents and self-management tools, are more likely
to receive insulin for more intensive blood glucose reduction.26, 79 Another observation that may
seem counterintuitive was that patients with graduate level education were more likely to be
uncontrolled than patients with college level education. There was no difference found in
glycemic control among other categories of educational attainment. The evidence on the effect of
educational attainment on glycemic control in the literature is mixed. Some studies have found
educational status to be a strong predictor of glycemic control while others have found no
association. 80, 81 The counterintuitive findings in this study makes sense, when combined with
physician’s perceptions, according to whom, patients often do not seek follow-up care as they
feel they have enough knowledge of their disease.
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Adherence has always been a challenge in any disease area with an average documented
adherence rate of 24.8%.82 A variety of factors influence adherence rates including treatmentrelated factors (dosing, administration, side effects), social and financial factors (copays,
insurance coverage, access, social support), patient related factors (health literacy, motivation),
health team and system factors (communication, provision of care), and condition specific
factors (comorbidities, depression).82 Adherence is a patient-reported outcome and ultimately,
the patient is responsible for keeping up with prescribed treatment regimens. Establishment of
therapeutic relationship that improves patient knowledge and self-management skills is essential
in improving adherence. It is also important to address patient motivation, which often is the
hardest patient factor to target.78, 82 In this study, we assessed patient motivation and readiness to
change self-management behaviors using a readiness ruler, where a majority of patients (67.9%)
reported being in the “action” or “maintenance” phase of changing their diabetes-related selfcare behaviors. Moreover, the self-management scores reported on the DSMQ questionnaire
were also high (> 5) for a majority of respondents (91.6%). Despite the higher readiness to
change self-care behaviors, the patients were found to have low knowledge of diabetes on the
DHL instrument with 75.7% patients unable to answer more than half the questions (> 5)
correctly. The findings strongly suggest that these patients practice good self-management, and
are willing to change their self-care behaviors, but a rate-limiting step in moving from
“uncontrolled” to “controlled” HbA1c level could be their low knowledge regarding the disease.
Use of multiple measures which can explore different aspects of patient knowledge may help
tease out these differences. Clearly, this aspect needs to be further explored and if it is the case,
then future interventions such as in-clinic diabetes education programs can be designed to
selectively target these areas and improve patient knowledge of diabetes. These findings also
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underscore the importance of comprehensive assessment of all these aspects of diabetes
management to provide a complete picture of patient’s self-management behaviors.
In addition to knowledge of T2DM, attitudes and beliefs of patients about their treatment
and illness are important determinants of self-management and glycemic control. The attitudes
and beliefs of patients with better self-care behaviors have been found to be different from
patients with poor self-care behaviors, and are more in accordance with the views of medical
experts.85 Previous studies have also found strong associations between patient perceptions of
their treatment and illness, and adherence to medications, diet and regular exercise.86 The current
study employed the revised version of the Illness Perception Questionnaire (IPQ-R), an
instrument validated in T2DM population.64 The responses on different domains within this scale
suggest that a majority of patients perceived their disease to be chronic in nature, and a serious
condition that had major consequences on their lives. They, however, believed that they could
control the course of their illness, through proper treatment control. A majority of patients
believed they understood their disease; which is in sharp contrast to their performance on the
DHL questionnaire, where a majority of respondents demonstrated poor knowledge of the
disease. This is indicative of patients perceiving good general awareness of their disease while,
in fact, not having enough knowledge about the specific symptoms and risks associated with
T2DM. This concern was also raised by their physicians in the physician survey, who cited
patient’s perception of having adequate knowledge of diabetes as a reason for lack of follow-up
care. A majority of patients reported that they do not have negative emotional representations
with respect to T2DM, such as feeling upset, anxious, depressed, worried, afraid or angry
because of their illness. A small proportion of patients (around 10-15%, refer Table 4.6),
however, reported having at least one of these emotional representations. This warrants an
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investigation about whether the attitudes and beliefs about T2DM in this population relate to
outcomes such as self-management and glycemic control. Existing literature underscores the
importance of attitudes and health beliefs in improving diabetes care outcomes, and some studies
have suggested use of educational tools to modify these beliefs and improve DSM.85-88 The
American Diabetes Association (ADA) has called for an individualized assessment and
development of an educational plan, which takes into account relevant medical history, cultural
influences, health beliefs and attitudes, diabetes knowledge, self-management skills and
behaviors, readiness to learn, cognitive ability, physical limitations, family support, and financial
status.88
Previous studies have shown that concordance between perceptions of patients and their
physicians about self-care behaviors is associated with improved self-care.88 Successful
management of T2DM requires collaborative efforts between patients an\d their physicians.89
These efforts involve improving patient-physician communication, patient-health literacy, and
addressing specific barriers to self-care in these patients.89-91 Pharmacist-led interventions such
as Medication Therapy Management (MTM) services can be used to improve patient health
literacy, overall self-management and self-efficacy in patients with T2DM.91 In addition to this,
strategies and policies that focus on improving medication adherence in this population may
have the potential for cost savings to the healthcare system and improved health outcomes to the
patients.92 In this study, we sought to examine physician perceptions about self-care behaviors of
their T2DM patients and the discordance between their perceptions and their patients’. The
physician group in this study perceived the diabetes related self-care activities to be extremely
important for overall management of T2DM; however, their perceptions about how difficult their
patients perceived these activities varied considerably. The physicians acknowledged that
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patient-physician communication, patient health literacy, and patient follow up are extremely
important aspects of providing quality care to their patients; a majority of them considered the
performance of their practices on these measures average or good, and a majority of them were
at least satisfied with their performance. Physicians who rated their performance and satisfaction
with patient follow-up and satisfaction with patient health literacy were more likely to consider
themselves responsible for patients’ failure to achieve self-management goals. An area where the
discordance between patient and physician perceptions was highlighted in this study was
patients’ knowledge of the disease. Physicians cited that patients often do not seek follow-up
care, as they perceive they have adequate knowledge of the disease. Interventions such as MTM
services, or in-clinic patient education, can help identify and narrow such gaps in perceptions of
patients and their providers.
A sizable proportion of physicians considered inability to afford follow-up care as a
reason for not seeking follow-up care by their patients. Our analysis showed that a higher
proportion of patients with Medicaid as a source of insurance, privately insured patients and
those with other sources of insurance had moderately or severely uncontrolled HbA1c levels, as
compared to patients with Medicare as a source of insurance. This finding is contrary to a
published retrospective study, which found that Medicare beneficiaries were more likely to be
uncontrolled as compared to privately insured individuals.93 The mixed evidence regarding the
association of type of insurance coverage with glycemic control may be due to systematic
differences in the study populations. However, it is important to note that type of insurance
coverage may affect receipt of follow-up care, and consequentially diabetes-management, and
future studies should explore this association further. The physicians cited inability to control
their patients’ HbA1c levels as a reason for referral to an endocrinologist. This is consistent with
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the finding from the current patient survey that a higher proportion of patients who were
moderately or severely uncontrolled received a referral to an endocrinologist.
Key Takeaway Findings
In this study, patient characteristics such as age, diabetes self-management, willingness to
take insulin, educational status, insurance status, and referral to an endocrinologist were
associated with glycemic control. Specifically, better self-management, as measured by DSMQ
scores, older age, and higher education predicted optimal glycemic control. Diabetes selfmanagement and referral to an endocrinologist were also associated with the patient’s readiness
to change their diabetes self-care behaviors. Physicians in this study perceived practice
characteristics to be very/extremely important. Considerable variation was observed in their
perceptions about performance and satisfaction about these characteristics. Self-care activities
were perceived to be very important. Recommended diet and exercise were perceived to be more
difficult to follow than adhering to insulin or oral medications.
The perceived knowledge of disease and illness coherence of patients measured by the
IPQ-R questionnaire was high in a majority of the respondents; their performance on the DHL
questionnaire, however, was poor, with a majority of respondents unable to answer more than
50% questions correctly. This discrepancy in perceived knowledge and actual knowledge of the
disease was highlighted by the physicians as well; they expressed frustration about patients not
seeking follow-up care, thinking that they have enough knowledge of their disease. The
pharmacist led intervention can target this area and focus on improving patient knowledge of
their T2DM, through in clinic diabetes education.
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Strengths
This is one of the few studies that looked at the perspectives of both patients and their
physicians for comprehensive assessment of patient barriers and facilitators to DSM. Moreover,
few studies in the past have combined EMR data with self-reported survey data for assessment of
barriers and facilitators to DSM. Combining these data enabled validation of survey responses
through the variables in the EMR data, and also provided additional clinical information about
the respondent, such as comorbidities, medications, and BMI, which would have been difficult to
capture accurately through surveys alone. The stratified sampling technique employed in this
study allowed us to get adequate responses from all three strata. The results of this study not only
help identify the predictors of glycemic control in this population, but also identify areas of
discordance between physicians and their patients. These aspects can serve as targets for
interventions aimed at improving glycemic control and DSM in this population.
Limitations
This study is not without limitations. The patient sample consisted of 210 responses,
which translates to a 10% response rate, which is significantly lower than the response rates
observed in the literature. However, this sample size was sufficient to conduct the proposed
analyses. Non-response bias is a potential threat to the study findings, when responses are
collected through mail-based surveys. There were no significant differences in the characteristics
of early vs. responders, which suggest that non-response bias was not a threat to this study. The
potential reason for a low response for this study, was the absence of multiple mailing and
reminder post-card, in accordance with the Dillman survey method, due to funding constraints.
The patient survey was also moderately long, requiring approximately 15 minutes of patient’s
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time to complete. The potential respondent burden associated with the survey could have also
contributed to the low response rate.
As with any other self-reported survey study, this study may have suffered from certain
biases. Social desirability bias occurs when a respondent exaggerates, or hides a true response,
because they are too embarrassed to reveal private information. In this study, the respondents
were asked several questions about their attitudes, beliefs, and self-management behaviors,
where their responses could have been biased. To avoid or minimize this bias, we employed
standardized questionnaires validated in T2DM population, in the patient survey. The survey also
captured clinical information such as the patient’s most recent HbA1c level, comorbidities, and
so on. This could result in recall bias. A comparison of the HbA1c levels from self-report to the
HbA1c levels recorded in EMR data showed a very high correlation, suggesting that recall bias
was not a threat to this study.
Future Directions
The patient sample in this study is predominantly Caucasian. Though this sample is
representative of southwestern PA, the generalizability of the study findings to other, more
diverse populations, is suspect. Future studies should replicate this study in larger, more diverse
samples, and examine if the findings are consistent with the current study. As a natural next step
to this study, a pharmacist led intervention that targets the identified predictors, and specifically
focuses on improving patient knowledge of their disease, could be implemented. A cost-benefit
analysis of this intervention can then be performed to assess its effectiveness, and examine if it is
feasible to implement such an intervention on a larger scale.
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Overall Conclusions
The findings of this study underscore the importance of DSM in the overall management
of T2DM. Understanding the barriers and facilitators to DSM, common to patients and their
providers, while also identifying and addressing the discordance between them regarding various
aspects of patient care can improve care and outcomes. Interventions including clinical services
that facilitate collaborative relationships between providers and their patients are crucial in
enhancing the overall management of T2DM.
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